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What’s already known about this topic?  
 Fetal surgery, both open and fetoscopic, is now widely performed.  
 Fetoscopy is perceived as safe for the mother, although specific data on 
maternal complications is lacking. 
 Open fetal surgery is known to cause maternal morbidity, but the exact nature 
and frequency of complications is not well established across different centres 
and types of surgery.  
 
What does this study add? 
 This study estimates the nature and frequency of maternal complications 
following fetoscopic and open fetal surgery. 
 For open fetal surgery the severe complication rate (Grade III to V according to 
the Clavien-Dindo classification of surgical complications) is approximately 4% 
and minor complication rate is 16%. 
 For fetoscopic fetal surgery the severe complication rate is approximately 2% 
and minor complication rate is 4%. 
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Abstract  
 
Objective  
To establish maternal complication rates for fetoscopic or open fetal surgery. 
 
Methods  
We conducted a systematic literature review for studies of fetoscopic or open fetal 
surgery performed since 1990, recording maternal complications during fetal surgery, 
the remainder of pregnancy, delivery and after the index pregnancy. 
 
Results  
One hundred and sixty-six studies were included, reporting outcomes for open fetal 
(n=1193 patients) and fetoscopic surgery (n=9403 patients). No maternal deaths were 
reported. The risk of any maternal complication in the index pregnancy was 20.9% 
(95%CI 15.22-27.13) for open fetal and 6.2% (95%CI 4.93-7.49) for fetoscopic 
surgery. For severe maternal complications (Grade III to V Clavien-Dindo classification 
of surgical complications) the risk was 4.5% (95%CI 3.24-5.98) for open fetal and 1.7% 
(95%CI 1.19-2.20) for fetoscopic surgery. In subsequent pregnancies, open fetal 
surgery increased the risk of preterm birth but not uterine dehiscence or rupture. 
Nearly one quarter of reviewed studies (n=175, 23.3%) were excluded for failing to 
report the presence or absence of maternal complications. 
 
Conclusions 
Maternal complications occur in 6.2% fetoscopic and 20.9% open fetal surgeries, with 
serious maternal complications in 1.7% fetoscopic and 4.5% open procedures. 
  
This article is protected by copyright. All rights reserved. 
Reporting of maternal complications is variable. To properly quantify maternal risks, 
outcomes should be reported consistently across all fetal surgery studies. 
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Introduction 
 
The last 35 years have witnessed an expansion of fetal therapy options1 2, with surgery 
on the fetus, placenta, or cord now relatively common in tertiary-level fetal medicine 
units. Enabled by advancements in imaging, surgical instrumentation and techniques, 
early diagnosis and treatment of fetal anomalies is now possible for a wide range of 
conditions3.  
 
The mother has been called an “innocent bystander” in fetal surgery4 and generally 
fetal therapy is almost exclusively offered to women who are healthy themselves. Fetal 
surgery poses risks to the mother not only during the procedure itself but also 
throughout the remainder of the index pregnancy, potentially during any future 
pregnancies and throughout the woman’s entire life. Fetal surgery offers no direct 
medical benefit to the mother, and from an ethical perspective maternal risks should 
be minor and acceptable to the mother and family5.  
 
Information regarding safety of surgery is important for counselling and informed 
decision making; however, robust data on maternal complications of fetal surgery are 
lacking. One single-centre study of maternal outcomes following both open fetal and 
fetoscopic surgery performed between 1989 and 2003 found a number of short-term 
morbidities6. A systematic review of maternal complications following fetoscopic laser 
coagulation for twin-to-twin transfusion syndrome (TTTS) in 1785 patients treated 
between 1990 and 20097 observed an overall adverse event rate of 5.4% with severe 
complications in 1.0%. The aim of this study was to estimate the incidence of 
immediate and long-term maternal complications of fetoscopic or open fetal surgery 
through a systematic review of the literature.   
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Methods 
 
Protocol and Registration 
This systematic review was conducted in accordance with Preferred Reporting Items 
for Systematic reviews and Meta‐analyses (PRISMA) guidance8. The protocol was 
registered with the International Prospective Register of Systematic Reviews 
(PROSPERO-CRD42017082411). 
 
Eligibility criteria 
All randomised, cohort and case-controlled studies and case series reporting the 
results of open fetal or fetoscopic fetal surgery in humans from January 1990 to 
October 2018 were considered eligible. No language restrictions were applied. 
Systematic reviews, narrative review articles and case reports were excluded. There 
is no accepted numerical definition of a case series9. We used an empirical cut-off of 
at least three cases because of the rarity of some procedures and conditions searched 
for.  
 
Search strategy 
A systematic review was conducted in MEDLINE, EMBASE and Cochrane databases 
using free text and Medical Subject Headings (MESH). The electronic search strategy 
is described in Supplement 1. Subsequently, a grey literature (first 100 hits in Pubmed 
and Google Scholar) search was performed, and reference lists of relevant review 
articles were manually checked. Covidence software (Veritas Health Innovation Ltd, 
Melbourne, Australia) was used to eliminate duplicate articles and manage study 
screening. 
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Study selection 
Two authors (A.S. and L.VdV.) screened all titles and abstracts independently, 
excluded irrelevant studies and then independently assessed the remaining full-text 
articles for eligibility; disagreements were resolved by consensus. Studies were 
excluded if the full text was unavailable online and the abstract contained insufficient 
information. Studies with interventions which were not fully described or were 
performed on the neonate instead of the fetus were excluded. Interventions involving 
access to the uterus using a device with a total outer diameter of <1.5mm were 
excluded; this cut-off was chosen to avoid procedures performed with needles only 
(e.g. amniocentesis, fetal blood transfusion, thoraco- or vesicocentesis etc.). Studies 
of shunting were only included if the outer shunt diameter was ≥1.5mm or the shunt 
was inserted fetoscopically. Studies which did not report maternal outcomes were 
excluded. For the purpose of this study, preterm rupture of membranes (PROM), 
chorionic membrane separation (CMS), preterm labour, preterm delivery and 
gestational age at delivery, though relevant, were not considered to be maternal 
complications. Studies from which data could not be extracted (e.g. composite or 
combined outcomes given) and studies containing patient cohorts which appeared to 
have been published previously by the same authors were excluded. 
 
Data extraction 
Two authors independently extracted data (A.S. and E.B. for open fetal surgery 
studies, A.S. and C.F. for fetoscopic studies) and entered them into a standardised 
Excel (Microsoft, Washington, USA) form. Disagreements were resolved by 
consensus. The ex-utero intrapartum treatment (EXIT) procedure was classified as 
open fetal surgery. Study characteristics noted included study design, underlying fetal 
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condition, type of intervention, presence of a control group, gestational age at surgery 
and number of patients in each study. Outcomes recorded for the duration of the index 
pregnancy included intra-operative complications (maternal death, placental 
abruption, uterine bleeding/haemorrhage, blood transfusion, organ damage or 
anaesthetic complications), post-operative complications (classified from the end of 
surgery until delivery; maternal death, placental abruption, uterine bleeding/ 
haemorrhage, blood transfusion, sepsis, chorioamnionitis, other infections, pulmonary 
oedema, amniotic fluid embolism and other respiratory, gastro-intestinal, cardiac or 
wound problems), complications at delivery of the index pregnancy (uterine 
dehiscence or rupture or blood transfusion) and the need for additional treatment at 
any time during the pregnancy. Outcomes noted at any time following the index 
pregnancy (late outcomes) included fertility (number of further pregnancies, difficulty 
conceiving, mean time to conception), future pregnancy complications (miscarriage or 
pre-term delivery), complications during future deliveries (uterine dehiscence or 
rupture or haemorrhage at delivery), gynaecological and psychological symptoms. 
When a study reported “haemorrhage” or an actual blood loss of ≥1000mL we noted 
this as “haemorrhage”. This cut-off is an accepted definition of severe bleeding both 
in pregnancy10 and post-partum11. If a study did not specify whether a complication 
occurred intra- or post-operatively (e.g. placental abruption, requirement for blood 
transfusion) then this was assumed to have occurred post-operatively. 
All complications were independently graded according to the Clavien-Dindo 
classification of surgical complications12 by two authors (A.S. and L.VdV.) 
(Supplement 2). Clavien-Dindo grade I or II complications were defined as mild; grade 
III to V complications were defined as severe12. 
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Quality assessment of studies 
Study quality and risk of bias were analysed by two authors (A.S. and L.VdV.) 
independently using a standardised form. Randomised trials were analysed using the 
Cochrane Collaboration’s tool for assessing risk of bias13. Case-control studies were 
analysed using the Newcastle-Ottawa scale for assessing the quality of non-
randomised studies14. Case series were analysed using the National Institutes of 
Health study quality assessment tool15.  
 
Assessment of heterogeneity 
Methodological and clinical heterogeneity of data per study were evaluated. Variables 
were tested for statistical heterogeneity by applying the I2 test to determine whether 
data could be pooled. An I2 value less than 40% was taken to indicate minor 
heterogeneity; 40-75% moderate heterogeneity and >75% substantial 
heterogeneity13. 
 
Meta-analysis 
Meta-analysis for all outcomes was carried out using MedCalc statistical software 
version 15.4 (MedCalc Software, Ostend, Belgium). Results were expressed as 
proportions with 95% confidence intervals (CI) as all outcomes were categorical 
variables. Pooled proportions were calculated using both the fixed and random effects 
model in case of homogeneity or heterogeneity respectively.  
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Results 
Study selection 
The electronic literature search identified 70,367 studies published between 1990 and 
2018 (Figure 1); search of the grey literature and reference lists identified a further 16 
studies. Following this, 48,248 studies were immediately removed as duplicates. The 
remaining studies (22,135) were screened by title and abstract, and a further 21,384 
were excluded as irrelevant. Full texts of the remaining 751 articles were reviewed, 
and 585 were excluded for the following reasons: no reporting of maternal outcomes 
(175/585, 29.9% of studies excluded and 23.3% [175/751] of all studies assessed), 
insufficient information available (conference abstract/poster only or full text 
unavailable) (119/585, 20.3%), study design other than randomised trial, case-control 
trial or case series (110/585, 18.8%) and uterine access using a device <1.5mm 
(59/585, 10.1%). Thirty studies were translated from French (10), Spanish (7), Polish 
(5), German (3), Dutch (2), Portuguese (2) and Turkish (1), of which 16 were included 
following review. Two Chinese-language papers were identified but the full text could 
not be accessed online. Eventually 166 studies were included; 41 on open fetal 
surgery, 122 on fetoscopic surgery and three studies including both surgery types. 
 
Study characteristics 
Characteristics of included studies are shown in Tables 1-3. Studies of open fetal 
(Table 1) and fetoscopic (Table 2) surgery are presented and analysed separately as 
the difference in surgical technique was considered too great for combined analysis. 
Seven studies specifically focused on late complications, i.e. after the index 
pregnancy, and are presented separately (Table 3). The majority of studies (68.1%, 
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113/166) were case series i.e. without a control group; 27.1% (45/166) were case 
control studies and 4.8% (8/166) were randomised trials. 
 
Risk of bias 
Quality assessment of the studies is given in Supplement 3. Most studies (139/166, 
83.7%) had a low risk of bias or were high quality. All remaining studies (27/166, 
16.3%) had an unclear risk of bias or were fair quality. No studies were found to have 
a high risk of bias or be low quality overall. For randomised trials, included studies had 
a high risk of bias with regards to blinding. For case control studies, included studies 
did not describe statistical methods well overall. 
 
Statistical heterogeneity 
Maternal outcome data was pooled in 64 separate meta-analyses, of which 37.5% 
(24/64) had no or minor heterogeneity. In 39.1% (25/64) there was moderate 
heterogeneity and in 23.4% (15/64) there was considerable heterogeneity. The levels 
of heterogeneity per outcome measure are listed in Supplement 4. As both clinical and 
statistical heterogeneity were found, pooled proportions were given using the random 
effects model for meta-analysis. 
 
Maternal complications in the index pregnancy - intra-operative  
Table 4 summarises maternal complications according to type of surgery performed. 
No maternal deaths (Clavien-Dindo grade V) due to fetal surgery were reported in any 
study (10,596 procedures). One study16 reported a patient at 20 weeks’ gestation 
experiencing a cardio-respiratory arrest prior to fetoscopy for laser photocoagulation. 
The cause was considered to be a combination of morbid obesity, spinal anaesthesia 
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and aorto-caval compression, and not related to the procedure which had not 
commenced. An immediate delivery was conducted by hysterotomy as part of 
maternal resuscitation and the patient made a full recovery. Another study17 reported 
brief maternal seizure-like activity during open fetal surgery, which was thought to be 
anaesthesia-related. 
 
Haemorrhage severe enough to prompt delivery or termination of pregnancy at the 
time of surgery as a life-saving procedure for the mother (Clavien-Dindo grade III) 
occurred in 0.92% of open fetal (95% CI 0.46-1.62) and 0.26% of fetoscopic surgeries 
(95% CI 0.17-0.38). Three cases18 19 20 occurred due to placental abruption during 
open fetal surgery for myelomeningocele (MMC) repair, following which delivery 
occurred, with all three fetuses surviving. Two cases21 22 occurred following laser 
photocoagulation for TTTS said to be due to “excessive bleeding from placental 
anastomoses” and the uterine wall respectively. Two cases23 24 occurred during 
selective reduction, with haemorrhage from the uterine wall prompting delivery. Finally, 
one pregnancy was terminated due to bleeding from a trocar placental injury during 
fetoscopic MMC repair.25  
 
In total, placental abruption (Clavien-Dindo grade III) occurred intraoperatively in 
1.28% of open fetal (95% CI 0.73-1.98) and in 0.28% of fetoscopic surgeries (95% CI 
0.18-0.39). Bleeding during the procedure was noted in 1.97% of open fetal (95% CI 
0.97-3.31) and in 1.74% of fetoscopic surgery cases (95% CI 1.25-2.32). Intra-
operative blood transfusion was required in 1.00% of patients undergoing open fetal 
surgery (95% CI 0.53-1.64) and in 0.27% undergoing fetoscopic surgery (95% CI 0.18-
0.38). Intra-operative skin burns at the site of diathermy pads occurred in 0.26% of 
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patients (95% CI 0.17-0.37) during fetoscopic surgery; this outcome was not reported 
in any open fetal surgery. 
 
Maternal complications in the index pregnancy - postoperative 
One study on laser photocoagulation for TTTS (n=132)26 reported a maternal death 
from disseminated intravascular coagulation (DIC) four weeks following an uneventful 
procedure. A post-mortem examination did not find any evidence of chorioamnionitis 
or amniotic fluid embolism and the authors therefore concluded that this death was 
unrelated to the procedure.  
 
Haemorrhage severe enough to prompt return to theatre for termination or delivery of 
the pregnancy within 24 hours was not reported following any open fetal surgeries but 
occurred following 0.25% of fetoscopic procedures (95% CI 0.16-0.37). This included 
one27 four hours post-fetoscopic tracheal balloon removal with no cause of the 
bleeding found. There were two late placental abruptions, one28 12 hours post-laser 
photocoagulation and one29 within 24 hours of bipolar cord coagulation. 
 
Placental abruption occurred in 1.80% of patients following open fetal (95% CI 1.14-
2.63) and in 1.29% following fetoscopic surgery (95% CI 0.90-1.75). Post-operative 
blood transfusion was given to 3.36% after open fetal surgery (95% CI 1.85-5.29) and 
in 0.32% following fetoscopic surgery (95% CI 0.22-0.44). 
 
Chorioamnionitis following open fetal surgery or endometritis following an EXIT 
procedure occurred in 4.13% of women (95% CI 3.03-5.40), and in 1.45% undergoing 
fetoscopic surgery (95% CI 1.06-1.90). Of those, PROM was reported to have 
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occurred in 47.78% following open fetal surgery (95% CI 23.01-73.16) and in 36.31% 
following fetoscopic surgery (95% CI 22.00-51.99). One study reported severe 
chorioamnionitis five days after bipolar cord coagulation30 with septic shock and acute 
kidney injury which resolved leaving 70% residual renal function. Sepsis was also 
reported in one patient31 with chorioamnionitis following fetoscopic laser 
photocoagulation and in one patient32 following open MMC repair who developed post-
operative peritonitis requiring an emergency laparotomy and delivery. Post-operative 
pneumonia occurred in two patients - one33 following fetoscopic radiofrequency 
ablation (RFA), necessitating three days of intubation and intensive care unit (ICU) 
care; and one requiring ICU admission 34 following open MMC repair.   
 
Pulmonary oedema occurred in 4.32% of open fetal surgery cases (95% CI 2.32-6.90), 
and in 0.63% of fetoscopic cases (95% CI 0.43-0.87). Three studies in which post-
operative pulmonary oedema occurred reported on peri-operative fluid management 
(3/102, 2.9%) and 33 reported on the use of magnesium sulphate (33/102, 32.4%) 
without specifically suggesting causality. Six women required ICU admission, with four 
requiring intubation and ventilation; three following open fetal surgery6 35 and three 
following fetoscopic surgery36 37 38.  
 
Maternal complications in the index pregnancy - at delivery 
Only a few fetoscopic surgery studies (4/121 studies, 0.33%) reported findings or 
complications at delivery. Complications at delivery following open fetal surgery are 
shown in Table 4. Hysterectomy at or around the time of delivery was reported in two 
patients (Clavien-Dindo grade III). In one case39, caesarean delivery following open 
MMC repair in a woman with two previous caesareans, intra-abdominal scarring and 
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friable tissue eventually resulted in hysterectomy. In the second case38 following laser 
photocoagulation for TTTS and PROM, a caesarean section was performed at 33 
weeks’ gestation. A hysterectomy was eventually required due to haemorrhage with 
DIC and the patient spent five days in ICU, where she also experienced an iatrogenic 
pneumothorax. 
 
Uterine rupture occurred in 0.90% of patients at delivery following open fetal surgery 
(excluding EXIT procedures) in the index pregnancy (95% CI 0.41-1.59), and uterine 
dehiscence occurred in 3.67% (95% CI 2.01-5.81). Blood transfusion was given to 
1.83% of women (95% CI 1.16-2.65) at delivery following open fetal surgery. 
 
Overall maternal complication rates 
Table 4 displays maternal complications. In open fetal surgery there was a 4.51% 
severe (95% CI 3.24-5.98), a 16.26% minor complication rate (95% CI 11.17-22.09), 
and a total complication rate of 20.86% (95% CI 15.22-27.13).  For fetoscopic surgery, 
the corresponding rates were: 1.66% severe (95% CI 1.19-2.20), 4.33% minor (95% 
CI 3.33-5.45) and 6.15% total complications (95% CI 4.93-7.49). Complication rates 
in the six commonest fetal surgical procedures performed are displayed in Table 5. 
 
Maternal outcomes following the index pregnancy (long-term) 
Table 6 shows subsequent pregnancy outcomes and long-term maternal outcomes 
following a pregnancy in which fetal surgery was performed. New difficulties in 
conceiving were described in 3.81% of women after open fetal surgery (95% CI 1.22-
7.76, reported in four studies); this outcome was not reported to occur after fetoscopic 
surgery (three studies). Pregnancy loss prior to 24 weeks’ gestation occurred in 
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19.95% of pregnancies conceived following open fetal surgery (95% CI 13.37-27.48, 
three studies) and 13.67% of pregnancies conceived after fetoscopic surgery (95% CI 
9.34-18.68, three studies). Preterm birth occurred in 20.49% of pregnancies following 
open fetal surgery (95% CI 10.48-32.81, four studies) and in 2.12% of pregnancies 
following fetoscopic surgery (95% CI 0.02-9.01; three studies). Uterine rupture or 
dehiscence occurred respectively in 6.89% (95% CI 1.34-16.27, reported in three 
studies) and 11.09% (95% CI 5.34-18.59) of pregnancies following open fetal surgery. 
None were mentioned in fetoscopy studies. 
 
Discussion 
In this systematic review of the literature we found an overall complication rate of 
approximately 21% for open fetal surgery and 6% for fetoscopic fetal surgery, of which  
minor complications occurred in 16% and 4% of surgeries respectively. This maternal 
complication rate excludes obstetric complications which may also have occurred (e.g. 
PROM, CMS, preterm labour and preterm delivery). Additionally, many studies of fetal 
surgery fail to document maternal complications. Out of 751 full-text articles reviewed, 
175 (23.3%) were excluded as no maternal outcomes were stated. Although 68 of 
these studies focused on a specific aspect of the surgery or its neonatal outcome, 107 
studies (92 fetoscopic and 15 open) involving over 9000 patients did not comment on 
the presence or absence of any complications specifically affecting the mother’s 
health. Often the “maternal outcomes” stated meant in reality obstetric outcomes (e.g. 
PROM, preterm labour). We also found that maternal complications were often 
presented from the fetal perspective (e.g. fetal demise caused by placental abruption). 
Thirty included studies (18.1%) contained a statement that no adverse maternal 
outcomes were observed without specifying what was meant by maternal outcomes. 
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Among these studies were some large series, including a study of 201 patients 
undergoing fetoscopic tracheal balloon removal40 and studies of 20041 and 50042 
patients undergoing fetoscopic laser coagulation. It is unlikely that such large numbers 
of procedures had no maternal complications, and more likely that complications were 
either not perceived as serious, not reported and/or the patient follow-up was 
incomplete. This lack of reporting has most likely led to an underestimation of the 
actual risk of maternal complications in our meta-analysis. Conversely, when maternal 
complications were reported, there was a wide variability in which outcomes were 
discussed and how they were presented.   
 
There was a severe complication rate (Clavien-Dindo grade III or IV) of 4.5% in women 
undergoing open fetal surgery and 1.7% undergoing fetoscopic surgery. This is in 
keeping with a previous multi-centre review of maternal complications following laser 
photocoagulation for TTTS7 which found a 1.0% rate of severe complications and a 
5.4% total rate of complications across all studies; however, when the authors only 
included studies which systematically assessed maternal complications as a primary 
or secondary outcome, this rose to 1.8% for severe and 17.4% for all complications. 
 
In almost all studies of fetal surgery reviewed, long-term maternal follow up was not 
described. The seven studies that did so had a wide variation in the parameters 
described. Fertility does not appear to be negatively affected by fetal surgery, with the 
rates of de novo difficulties for conceiving in this review (3.81% following open fetal 
surgery and none following fetoscopic surgery) being comparable, if not less, than 
published rates of secondary infertility in the general population43. Similarly, the rates 
of miscarriage described (19.85% following open fetal and 13.67% following fetoscopic 
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surgery) are similar to rates of spontaneous miscarriage in women who have not 
undergone fetal surgery 44 45 46. Epidemiological studies47 have suggested a worldwide 
preterm birth rate of 11.1% with a rate of 8.6% in “developed regions”47. In the US and 
UK it is estimated at 9.8%48 and 7.3%49 respectively. The preterm birth rate in this 
review following open fetal surgery (20.49%) is higher than the usual prevalence, but 
not higher following fetoscopic surgery (2.12%). Open fetal surgery was followed by 
uterine rupture or dehiscence in 6.89% and 11.09% of subsequent pregnancies 
respectively, which is in line with published rates of rupture (6.2%) and dehiscence 
(12.5%) following a classical caesarean section50. Conversely, no uterine ruptures 
were reported following fetoscopic surgery.  
 
This study included the commonest fetal procedures and, from a maternal perspective, 
involved similar surgical manipulations yet variable operating times. We included 
studies from multiple centres worldwide and attempted to identify the non-English 
literature. It is therefore likely that these results are generalisable to fetal surgery 
performed outside the included studies. An obvious weakness of this systematic 
review is that most studies did not include a control group. Furthermore, we decided 
to pool data for meta-analysis despite having high heterogeneity in some results. 
Another weakness is the extraction of patient data from papers, which is prone to error 
given the variable reporting; it is possible that some patients had more than one 
complication and this was not noted or cumulative rates were as a consequence 
miscalculated.  
 
This systematic review has identified a significant rate of maternal complications, 
which should be discussed with patients before embarking on fetal surgery. Large 
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studies allow an estimation of the likelihood of these events, insomuch as the cases 
in these series are unselected and consecutive. Our systematic review search strategy 
may have missed relevant yet rare complications. For example, a letter to a journal 
editor describing maternal convulsions during general anaesthesia51 was excluded as 
a case report according to our criteria. In this circumstance, it appears the patient was 
also part of the cohort of a study that was included17, but it is possible that other rare 
events reported as case series have been missed. An international, prospective 
registry of fetal and fetoscopic surgery, such as the Eurofoetus52 and NAFTNet53 
registries, would be the best way to accurately determine complication types and rates 
and avoid missing rare complications.  
 
Conclusion 
The maternal risks of fetal surgery are accepted by many patients and healthcare 
professionals for the possible benefit to the fetus54 55. This systematic review finds that 
studies of fetal surgery focus on the fetal outcomes of the procedure, and many fail to 
describe maternal complications. Fetal surgery comes at a risk to the mother, which 
may be underestimated by fetal therapists due to under-reporting and variable 
reporting quality. In order to properly quantify maternal risks, outcomes should be 
reported consistently across all studies of fetal surgery, preferentially in prospective 
registries. 
 
 
 
 
 
  
This article is protected by copyright. All rights reserved. 
References 
 
1.  Deprest JA, Flake AW, Gratacos E, et al. The making of fetal surgery. Prenat Diagn. 
2010;30(7):653-667. doi:10.1002/pd.2571. 
2.  Jancelewicz T, Harrison MR. A history of fetal surgery. Clin Perinatol. 2009;36(2):227. 
doi:10.1016/j.clp.2009.03.007. 
3.  Deprest JA, Done E, Van Mieghem T, Gucciardo L. Fetal surgery for anesthesiologists. Curr 
Opin Anaesthesiol. 2008;21(3):298-307. doi:10.1097/ACO.0b013e3282ff8607. 
4.  Farrell JA, Albanese CT, Jennings RW, Kilpatrick SJ, Bratton BJ, Harrison MR. Maternal fertility 
is not affected by fetal surgery. Fetal Diagn Ther. 1999;14(3):190-192. 
http://gateway.proquest.com/openurl?ctx_ver=Z39.88-
2004&res_id=xri:pqm&req_dat=xri:pqil:pq_clntid=50325&rft_val_fmt=ori/fmt:kev:mtx:journal&g
enre=article&issn=1015-3837&volume=14&issue=3&spage=190. 
5.  Moon-Grady A, Baschat A, Cass D. Fetal Treatment 2017: The Evolution of Fetal Therapy 
Centers – A Joint Opinion from the International Fetal Medicine and Surgical Society (IFMSS) 
and the North American Fetal Therapy Network (NAFTNet). Fetal Diagn Ther. 2017;42:241-248. 
6.  Golombeck K, Ball RH, Lee H, et al. Maternal morbidity after maternal-fetal surgery. Am J Obstet 
Gynecol. 2006;194(3):834-839. http://www.hlisd.org/LibraryDetail.aspx?LibraryID=3866. 
7.  Merz W, Tchatcheva K, Gembruch U, Kohl T. Maternal complications of fetoscopic laser 
photocoagulation (FLP) for treatment of twin-twin transfusion syndrome (TTTS). J Perinat Med. 
2010;38(4):439-443. doi:10.1515/JPM.2010.061. 
8.  Moher D, Liberati A, Tetzlaff J, Altman D. The PRISMA Group (2009). Preferred Reporting Items 
for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med. 
(6(7)):e1000097. 
9.  Carey TS, Boden SD. A critical guide to case series reports. Spine (Phila Pa 1976). 
2003;28(15):1631-1634. doi:10.1097/01.BRS.0000083174.84050.E5. 
10.  The Royal College of Obstetricians and Gynaecologists. Antepartum Haemorrhage Green-top 
Guideline No. 63. 2011;(63). 
https://www.rcog.org.uk/globalassets/documents/guidelines/gtg_63.pdf. 
11.  Gulmezoglu AM, Souza JP, Mathai M. WHO Recommendations for the Prevention and 
  
This article is protected by copyright. All rights reserved. 
Treatment of Postpartum Haemorrhage.; 2012. doi:10.1016/j.ijgo.2013.06.024. 
12.  Dindo D, Demartines N, Clavien PA. Classification of surgical complications: A new proposal 
with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205-
213. doi:10.1097/01.sla.0000133083.54934.ae. 
13.  Higgins J, Green S. Assessing risk of bias in included studies. Cochrane Handb Syst Rev Interv. 
2008:187-241. 
14.  Wells G, Shea B, O’Connell D, Peterson J, Welcho V, Losos M. The Newcastle-Ottawa Scale 
(NOS) for assessing the quality of nonrandomized studies in meta-analyses. Ottawa Heal Res 
Inst. 2011. http://www.ohri.ca/programs/clinical_epidemiology/nos_manual.pdf 
15.  National Institutes of Health: Study Quality Assessment Tools. www.nhlbi.nih.gov/health-
topics/study-quality-assessment-tools. Published 2014. 
16.  Müllers SM, McAuliffe FM, Kent E, et al. Outcome following selective fetoscopic laser ablation 
for twin to twin transfusion syndrome: an 8 year national collaborative experience. Eur J Obstet 
Gynecol Reprod Biol. 2015;191:125-129. doi:10.1016/j.ejogrb.2015.05.019. 
17.  Sinskey JL, Rollins MD, Whitlock E, et al. Incidence and Management of Umbilical Artery Flow 
Abnormalities during Open Fetal Surgery. Fetal Diagn Ther. 2017. doi:10.1159/000477963. 
18.  Bruner JP, Tulipan N, Paschall RL, et al. Fetal surgery for myelomeningocele and the incidence 
of shunt-dependent hydrocephalus. JAMA. 1999;282(19):1819-1825. 
http://www.hlisd.org/LibraryDetail.aspx?LibraryID=3866. 
19.  Moron A, Barbosa M, Milani H, et al. Perinatal outcomes after open fetal surgery for 
myelomeningocele repair: a retrospective cohort study. BJOG An Int J Obstet Gynaecol. 
2018;[Epub ahea. doi:10.1111/1471-0528.15312. 
20.  Ochsenbein-Kölble N, Krähenmann F, Hüsler M, et al. Tocolysis for in utero Surgery: Atosiban 
Performs Distinctly Better than Magnesium Sulfate. Fetal Diagn Ther. 2017. 
doi:10.1159/000478261. 
21.  Chang J, Tracy TF, Carr SR, Sorrells DL, Luks FI. Port insertion and removal techniques to 
minimize premature rupture of the membranes in endoscopic fetal surgery. J Pediatr Surg. 
2006;41(5):905-909. 
22.  Huber A, Baschat AA, Bregenzer T, et al. Laser coagulation of placental anastomoses with a 30 
degrees fetoscope in severe mid-trimester twin-twin transfusion syndrome with anterior 
  
This article is protected by copyright. All rights reserved. 
placenta. Ultrasound Obstet Gynecol. 2008;31(4):412-416. doi:10.1002/uog.5283. 
23.  Delabaere A, Favre N, Velemir L, et al. Suivi pédiatrique de 30 grossesses gémellaires 
monochoriales consécutives traitées par fœticide sélectif. Gynecol Obstet Fertil. 2013;41(2):85-
89. doi:10.1016/j.gyobfe.2012.12.007. 
24.  Gallot D, Laurichesse H, Lemery D. Selective feticide in monochorionic twin pregnancies by 
ultrasound-guided umbilical cord occlusion. Ultrasound Obstet Gynecol. 2003;22(5):484-488. 
doi:10.1002/uog.917. 
25.  Kohl T, Tchatcheva K, Weinbach J, et al. Partial amniotic carbon dioxide insufflation (PACI) 
during minimally invasive fetoscopic surgery: early clinical experience in humans. Surg Endosc. 
2010;24(2):432-444. doi:10.1007/s00464-009-0579-z. 
26.  Ville Y, Hecher K, Gagnon A, Sebire N, Hyett J, Nicolaides K. Endoscopic laser coagulation in 
the management of severe twin-to-twin transfusion syndrome. Br J Obstet Gynaecol. 
1998;105(4):446-453. 
27.  Kohl T, Hering R, Van de Vondel P, et al. Analysis of the stepwise clinical introduction of 
experimental percutaneous fetoscopic surgical techniques for upcoming minimally invasive 
fetal cardiac interventions. Surg Endosc. 2006;20(7):1134-1143. 
http://gateway.proquest.com/openurl?ctx_ver=Z39.88-
2004&res_id=xri:pqm&req_dat=xri:pqil:pq_clntid=50325&rft_val_fmt=ori/fmt:kev:mtx:journal&g
enre=article&issn=1432-2218&volume=20&issue=7&spage=1134. 
28.  Yamamoto M, El Murr L, Robyr R, Leleu F, Takahashi Y, Ville Y. Incidence and impact of 
perioperative complications in 175 fetoscopy-guided laser coagulations of chorionic plate 
anastomoses in fetofetal transfusion syndrome before 26 weeks of gestation. Am J Obstet 
Gynecol. 2005;193(3):1110-1116. http://www.hlisd.org/LibraryDetail.aspx?LibraryID=3866. 
29.  Taylor MJO, Shalev E, Tanawattanacharoen S, et al. Ultrasound-guided umbilical cord occlusion 
using bipolar diathermy for Stage III/IV twin-twin transfusion syndrome. Prenat Diagn. 
2002;22(1):70-76. 
https://go.openathens.net/redirector/nhs?url=http%3A%2F%2Fonlinelibrary.wiley.com%2Fdoi
%2F10.1002%2Fpd.256%2Ffull. 
30.  Lewi L, Gratacos E, Ortibus E, et al. Pregnancy and infant outcome of 80 consecutive cord 
coagulations in complicated monochorionic multiple pregnancies. Am J Obstet Gynecol. 
  
This article is protected by copyright. All rights reserved. 
2006;194(3):782-789. http://www.hlisd.org/LibraryDetail.aspx?LibraryID=3866. 
31.  Chmait RH, Korst LM, Llanes A, Mullin P, Lee RH, Ouzounian JG. Perioperative characteristics 
associated with preterm birth in twin-twin transfusion syndrome treated by laser surgery. Am J 
Obstet Gynecol. 2013;209(3):264. doi:10.1016/j.ajog.2013.05.025. 
32.  Zamlynski J, Olejek A, Tomasz K. Comparison of prenatal and postnatal treatments of spina 
bifida in Poland – a non-randomized, single-center study. J Matern Neonatal Med. 
2014;27(14):1409-1417. 
33.  Moise KJKY, Johnson A, Nickeleit V, et al. Radiofrequency ablation for selective reduction in 
the complicated monochorionic gestation. Am J Obstet Gynecol. 2008;198(2):198.e1-198.e5. 
doi:10.1016/j.ajog.2007.07.043. 
34.  Bennett KA, Carroll MA, Shannon CN, et al. Reducing perinatal complications and preterm 
delivery for patients undergoing in utero closure of fetal myelomeningocele: further modifications 
to the multidisciplinary surgical technique. J Neurosurg Pediatr. 2014;14(1):108-114. 
doi:10.3171/2014.3.PEDS13266. 
35.  Flake AW, Crombleholme TM, Johnson MP, Howell LJ, Adzick NS. Treatment of severe 
congenital diaphragmatic hernia by fetal tracheal occlusion: clinical experience with fifteen 
cases. Am J Obstet Gynecol. 2000;183(5):1059-1066. 
http://www.hlisd.org/LibraryDetail.aspx?LibraryID=3866. 
36.  Duron VD, Watson-Smith D, Benzuly SE, et al. Maternal and fetal safety of fluid-restrictive 
general anesthesia for endoscopic fetal surgery in monochorionic twin gestations. J Clin Anesth. 
2014;26(3):184-190. doi:10.1016/j.jclinane.2013.10.010. 
37.  Nakata M, Ishii K, Sumie M, et al. A prospective pilot study of fetoscopic laser surgery for twin-
to-twin transfusion syndrome between 26 and 27 weeks of gestation. Taiwan J Obstet Gynecol. 
2016;55(4):512-514. doi:10.1016/j.tjog.2016.06.002. 
38.  Rustico MA, Lanna MM, Faiola S, et al. Fetal and maternal complications after selective 
fetoscopic laser surgery for twin-to-twin transfusion syndrome: a single-center experience. Fetal 
Diagn Ther. 2012;31(3):170-178. doi:10.1159/000336227. 
39.  Moldenhauer JS, Soni S, Rintoul NE, et al. Fetal myelomeningocele repair: the post-MOMS 
experience at the Children’s Hospital of Philadelphia. Fetal Diagn Ther. 2015;37(3):235-240. 
doi:10.1159/000365353. 
  
This article is protected by copyright. All rights reserved. 
40.  Jiménez JA, Eixarch E, DeKoninck P, et al. Balloon removal after fetoscopic endoluminal 
tracheal occlusion for congenital diaphragmatic hernia. Am J Obstet Gynecol. 2017;217(1):78. 
doi:10.1016/j.ajog.2017.02.041. 
41.  Hecher K, Diehl W, Zikulnig L, Vetter M, Hackelöer BJ. Endoscopic laser coagulation of placental 
anastomoses in 200 pregnancies with severe mid-trimester twin-to-twin transfusion syndrome. 
Eur J Obstet Gynecol Reprod Biol. 2000;92(1):135-139. 
42.  Martínez JM, Eixarch E, Crispi F, Puerto B, Gratacós E. Tratamiento por fetoscopia de la 
transfusión feto-fetal: Resultados en 500 casos consecutivos. Diagnostico Prenat. 
2012;23(3):102-108. doi:10.1016/j.diapre.2012.06.010. 
43.  Mascarenhas MN, Flaxman SR, Boerma T, Vanderpoel S, Stevens GA. National, Regional, and 
Global Trends in Infertility Prevalence Since 1990: A Systematic Analysis of 277 Health Surveys. 
PLoS Med. 2012;9(12):1-12. doi:10.1371/journal.pmed.1001356. 
44.  Wilcox A, Weinber C, O’Connor J, Baird D. Incidence of Early Pregnancy Loss. N Engl J Med. 
1988;319(4):189-194. 
45.  Andersen AN, Wohlfahrt J, Christens P, Olsen J, Melbye M, Nybo A. Maternal age and fetal 
loss: population based register linkage study. BMJ. 2000;320(June):1708-1712. 
46.  Herbert D, Lucke J, Dobson A. Pregnancy Losses In Young Australian Women. Findings from 
the Australian Longitudinal Study on Women’s Health. Women’s Heal Issues. 2009;19(1):21-29. 
doi:10.1016/j.whi.2008.08.007. 
47.  Blencowe H, Cousens S, Oestergaard MZ, et al. National, regional, and worldwide estimates of 
preterm birth rates in the year 2010 with time trends since 1990 for selected countries: A 
systematic analysis and implications. Lancet. 2012;379(9832):2162-2172. doi:10.1016/S0140-
6736(12)60820-4. 
48.  Tanne JH. Preterm and low weight births rise again in the US. BMJ. 2017;3311:j3311. 
doi:10.1136/bmj.j3311. 
49.  National Institute for Health and Care Excellence. Preterm labour and birth. 2015. 
nice.org.uk/guidance/ng25. 
50.  Greene RA, Fitzpatrick C, Turner MJ. What are the maternal implications of a classical 
caesarean section? J Obstet Gynaecol (Lahore). 1998;18(4):345-347. 
doi:10.1080/01443619867083. 
  
This article is protected by copyright. All rights reserved. 
51.  Shavit C, Rollins M, Ferschl M. Maternal convulsion during high-dose sevoflurane anaesthesia 
for open foetal surgery. Br J Anaesth. 2017;118(4):634-635. 
52.  Gratacós E, Deprest J. Current experience with fetoscopy and the Eurofoetus registry for 
fetoscopic procedures. Eur J Obstet Gynecol Reprod Biol. 2000;92(1):151-159. 
53.  NAFTNet Website. https://www.naftnet.org. 
54.  Bliton MJ. Parental hope confronting scientific uncertainty: a test of ethics in maternal-fetal 
surgery for spina bifida. Clin Obstet Gynecol. 2005;48(3):595-607. 
https://go.openathens.net/redirector/nhs?url=http%3A%2F%2Fovidsp.ovid.com%2Fovidweb.c
gi%3FT%3DJS%26PAGE%3Dfulltext%26MODE%3Dovid%26CSC%3DY%26NEWS%3DN%2
6D%3Dovft%26SEARCH%3D%252210.1097%2F01.grf.0000169660.80698.a8%2522.di. 
55.  Fry JT, Frader JE. “We want to do everything”: How parents represent their experiences with 
maternal-fetal surgery online. J Perinatol. 2018;38(3):226-232. doi:10.1038/s41372-017-0040-
4. 
56.  Barthod G, Teissier N, Bellarbi N, et al. Fetal airway management on placental support: 
limitations and ethical considerations in seven cases. J Obstet Gynaecol. 2013;33(8):787-794. 
doi:10.3109/01443615.2013.823924. 
57.  Cass DL, Olutoye OO, Cassady CI, et al. EXIT-to-resection for fetuses with large lung masses 
and persistent mediastinal compression near birth. J Pediatr Surg. 2013;48(1):138-144. 
doi:10.1016/j.jpedsurg.2012.10.067. 
58.  Chen XY, Yang JX, Zhang HY, et al. Ex utero intrapartum treatment for giant congenital 
omphalocele. World J Pediatr. 2018;(0123456789):1-5. doi:10.1007/s12519-018-0129-7. 
59.  Dahlgren G, Törnberg DC, Pregner K, Irestedt L. Four cases of the ex utero intrapartum 
treatment (EXIT) procedure: anesthetic implications. Int J Obstet Anesth. 2004;13(3):178-182. 
60.  George RB, Melnick AH, Rose EC, Habib AS. Case series: Combined spinal epidural 
anesthesia for Cesarean delivery and ex utero intrapartum treatment procedure. Can J 
Anaesth. 2007;54(3):218-222. http://gateway.proquest.com/openurl?ctx_ver=Z39.88-
2004&res_id=xri:pqm&req_dat=xri:pqil:pq_clntid=50325&rft_val_fmt=ori/fmt:kev:mtx:journal&g
enre=article&issn=0832-610X&volume=54&issue=3&spage=218. 
61.  Hedrick HL. Ex utero intrapartum therapy. Semin Pediatr Surg. 2003;12(3):190-195. 
62.  Hedrick HL, Flake AW, Crombleholme TM, et al. The ex utero intrapartum therapy procedure 
  
This article is protected by copyright. All rights reserved. 
for high-risk fetal lung lesions. J Pediatr Surg. 2005;40(6):1038-1044. 
doi:10.1016/j.jpedsurg.2005.03.024. 
63.  Kern C, Ange M, Morales, Peiry B, Pfister RE. Ex utero intrapartum treatment (EXIT), a 
resuscitation option for intra-thoracic foetal pathologies. Swiss Med Wkly. 2007;137(19-20):279-
285. 
64.  Kornacki J, Szydłowski J, Skrzypczak J, et al. Use of ex utero intrapartum treatment procedure 
in fetal neck and high airway anomalies – report of four clinical cases. J Matern Neonatal Med. 
2017;0(0):1-5. doi:10.1080/14767058.2017.1390740. 
65.  Kunisaki SM, Barnewolt CE, Estroff JA, et al. Ex utero intrapartum treatment with extracorporeal 
membrane oxygenation for severe congenital diaphragmatic hernia. J Pediatr Surg. 
2007;42(1):98. 
https://auth.elsevier.com/ShibAuth/institutionLogin?entityID=https://idp.eng.nhs.uk/openathens
&appReturnURL=https%3A%2F%2Fwww.clinicalkey.com%2Fcontent%2FplayBy%3Fissn%3D
0022-3468%26vol%3D42%26issue%3D1%26pgfirst%3D98. 
66.  Laje P, Johnson MP, Howell LJ, et al. Ex utero intrapartum treatment in the management of 
giant cervical teratomas. J Pediatr Surg. 2012;47(6):1208-1216. 
doi:10.1016/j.jpedsurg.2012.03.027. 
67.  Laje P, Howell LJ, Johnson MP, Hedrick HL, Flake AW, Adzick NS. Perinatal management of 
congenital oropharyngeal tumors: the ex utero intrapartum treatment (EXIT) approach. J Pediatr 
Surg. 2013;48(10):2005-2010. doi:10.1016/j.jpedsurg.2013.02.031. 
68.  Laje P, Peranteau WH, Hedrick HL, et al. Ex utero intrapartum treatment (EXIT) in the 
management of cervical lymphatic malformation. J Pediatr Surg. 2015;50(2):311-314. 
doi:10.1016/j.jpedsurg.2014.11.024. 
69.  Lazar DA, Olutoye OO, Moise KJ, et al. Ex-utero intrapartum treatment procedure for giant 
neck masses--fetal and maternal outcomes. J Pediatr Surg. 2011;46(5):817-822. 
doi:10.1016/j.jpedsurg.2011.02.006. 
70.  Noah MMS, Norton ME, Sandberg P, Esakoff T, Farrell J, Albanese CT. Short-term maternal 
outcomes that are associated with the EXIT procedure, as compared with cesarean delivery. 
Am J Obstet Gynecol. 2002;186(4):773-777. 
http://www.hlisd.org/LibraryDetail.aspx?LibraryID=3866. 
  
This article is protected by copyright. All rights reserved. 
71.  Pellicer M, Pumarola F, Peiró JL, et al. [EXIT procedure in the management of severe foetal 
airway obstruction. the paediatric otolaryngologist’s perspective]. Acta Otorrinolaringol Esp. 
2007;58(10):487-490. 
72.  Stoffan AP, Wilson JM, Jennings RW, Wilkins-Haug LE, Buchmiller TL. Does the ex utero 
intrapartum treatment to extracorporeal membrane oxygenation procedure change outcomes 
for high-risk patients with congenital diaphragmatic hernia? J Pediatr Surg. 2012;47(6):1053-
1057. doi:10.1016/j.jpedsurg.2012.03.004. 
73.  Tuncay Ozgunen F, Kucukgoz Gulec U, Evruke I., Agcabay C, Kadayifci T., Ozcan K. Fetal 
orofarengeal tumorler ve EXIT islemine dogum hekimi acisindan bakis [The point of view by 
obstetricians to fetal oropharengal tumors and EXIT procedure: Case report]. Turkiye Klin 
Jinekoloji Obstet. 2010;20(4):247-251. 
74.  Zamora IJ, Ethun CG, Evans LM, et al. Maternal morbidity and reproductive outcomes related 
to fetal surgery. J Pediatr Surg. 2013;48(5):951-955. doi:10.1016/j.jpedsurg.2013.02.010. 
75.  Botelho R, Imada V, Rodrigues da Costa K, Watanabe L, R RJ. Fetal Myelomeningocele Repair 
through a Mini-Hysterotomy. Fetal Diagn Ther. 2017;42(1):28-34. 
76.  Bruner JP, Tulipan NB, Richards WO, Walsh WF, Boehm FH, Vrabcak EK. In utero repair of 
myelomeningocele: a comparison of endoscopy and hysterotomy. Fetal Diagn Ther. 
2000;15(2):83-88. http://gateway.proquest.com/openurl?ctx_ver=Z39.88-
2004&res_id=xri:pqm&req_dat=xri:pqil:pq_clntid=50325&rft_val_fmt=ori/fmt:kev:mtx:journal&g
enre=article&issn=1015-3837&volume=15&issue=2&spage=83. 
77.  Farmer DL, von Koch CS, Peacock WJ, et al. In utero repair of myelomeningocele: experimental 
pathophysiology, initial clinical experience, and outcomes. Arch Surg. 2003;138(8):872-878. 
http://www.hlisd.org/LibraryDetail.aspx?LibraryID=3866. 
78.  Friszer S, Dhombres F, Di Rocco F, et al. [Preliminary results from the French study on prenatal 
repair for fetal myelomeningoceles (the PRIUM study)]. J Gynecol Obstet Biol Reprod (Paris). 
2016;45(7):738-744. doi:10.1016/j.jgyn.2015.09.002. 
79.  Johnson MP, Bennett KA, Rand L, et al. The Management of Myelomeningocele Study: 
obstetrical outcomes and risk factors for obstetrical complications following prenatal surgery. 
Am J Obstet Gynecol. 2016;215(6):778. doi:10.1016/j.ajog.2016.07.052. 
80.  Marenco ML, Márquez J, Ontanilla A, et al. [Intrauterine myelomeningocele repair: experience 
  
This article is protected by copyright. All rights reserved. 
of the fetal medicine and therapy program of the Virgen de Rocío University Hospital]. Rev Esp 
Anestesiol Reanim. 2013;60(1):47-53. doi:10.1016/j.redar.2012.07.011. 
81.  Soni S, Moldenhauer JS, Spinner SS, et al. Chorioamniotic membrane separation and preterm 
premature rupture of membranes complicating in utero myelomeningocele repair. Am J Obstet 
Gynecol. 2016;214(5):647. doi:10.1016/j.ajog.2015.12.003. 
82.  Harrison MR, Langer JC, Adzick NS, et al. Correction of congenital diaphragmatic hernia in 
utero, V. Initial clinical experience. J Pediatr Surg. 1990;25(1):47. 
83.  Harrison MR, Adzick NS, Flake AW, et al. Correction of congenital diaphragmatic hernia in utero: 
VI. Hard-earned lessons. J Pediatr Surg. 1993;28(10):1411. 
84.  Harrison MR, Mychaliska GB, Albanese CT, et al. Correction of congenital diaphragmatic hernia 
in utero IX: fetuses with poor prognosis (liver herniation and low lung-to-head ratio) can be saved 
by fetoscopic temporary tracheal occlusion. J Pediatr Surg. 1998;33(7):1017. 
85.  Adzick NS, Flake AW, Crombleholme TM. Management of congenital lung lesions. Semin 
Pediatr Surg. 2003;12(1):10-16. 
86.  Hedrick HL, Flake AW, Crombleholme TM, et al. Sacrococcygeal teratoma: prenatal 
assessment, fetal intervention, and outcome. J Pediatr Surg. 2004;39(3):430. 
87.  Longaker MT, Golbus MS, Filly RA, Rosen MA, Chang SW, Harrison MR. Maternal outcome 
after open fetal surgery. A review of the first 17 human cases. JAMA. 1991;265(6):737-741. 
http://www.hlisd.org/LibraryDetail.aspx?LibraryID=3866. 
88.  Aboudiab MS, Chon AH, Korst LM, Llanes A, Ouzounian JG, Chmait RH. Management of twin–
twin transfusion syndrome with an extremely short cervix. J Obstet Gynaecol (Lahore). 
2018;38(3):359-362. doi:10.1080/01443615.2017.1330324. 
89.  Baschat AA, Barber J, Pedersen N, Turan OM, Harman CR. Outcome after fetoscopic selective 
laser ablation of placental anastomoses vs equatorial laser dichorionization for the treatment of 
twin-to-twin transfusion syndrome. Am J Obstet Gynecol. 2013;209(3):234. 
doi:10.1016/j.ajog.2013.05.034. 
90.  Chalouhi GE, Quibel T, Benzina N, Bernard J-P, Essaoui M, Ville Y. [Outcome of triplet 
pregnancies managed for twin-to-twin transfusion syndrome: A single center experience]. J 
Gynecol Obstet Biol Reprod (Paris). 2016;45(8):929-935. doi:10.1016/j.jgyn.2015.08.006. 
91.  Chang Y-L, Chao A-S, Chang S-D, et al. Outcome of twin-twin transfusion syndrome treated by 
  
This article is protected by copyright. All rights reserved. 
laser therapy in Taiwan’s single center: Role of Quintero staging system. Taiwan J Obstet 
Gynecol. 2016;55(5):700-704. doi:10.1016/j.tjog.2015.05.006. 
92.  Chmait RH, Kontopoulos E V., Chon AH, Korst LM, Llanes A, Quintero RA. Amniopatch 
treatment of iatrogenic preterm premature rupture of membranes (iPPROM) after fetoscopic 
laser surgery for twin–twin transfusion syndrome. J Matern Neonatal Med. 2017;30(11):1349-
1354. doi:10.1080/14767058.2016.1214123. 
93.  Crombleholme TM, Shera D, Lee H, et al. A prospective, randomized, multicenter trial of 
amnioreduction vs selective fetoscopic laser photocoagulation for the treatment of severe twin-
twin transfusion syndrome. Am J Obstet Gynecol. 2007;197(4):396. 
https://auth.elsevier.com/ShibAuth/institutionLogin?entityID=https://idp.eng.nhs.uk/openathens
&appReturnURL=https%3A%2F%2Fwww.clinicalkey.com%2Fcontent%2FplayBy%2Fdoi%2F
%3Fv%3D10.1016%2Fj.ajog.2007.07.020. 
94.  De Lia JE, Kuhlmann RS, Harstad TW, Cruikshank DP. Fetoscopic laser ablation of placental 
vessels in severe previable twin-twin transfusion syndrome. Am J Obstet Gynecol. 
1995;172(4):1202. http://www.hlisd.org/LibraryDetail.aspx?LibraryID=3866. 
95.  De Lia JE, Kuhlmann RS, Lopez KP. Treating previable twin-twin transfusion syndrome with 
fetoscopic laser surgery: outcomes following the learning curve. J Perinat Med. 1999;27(1):61-
67. 
96.  De Lia JE, Worthington D, Carr MH, Graupe MH, Melone PJ. Placental laser surgery for severe 
previable feto-fetal transfusion syndrome in triplet gestation. Am J Perinatol. 2009;26(8):559-
564. doi:10.1055/s-0029-1220789. 
97.  Deprest JA, Van Schoubroeck D, Van Ballaer PP, Flageole H, Van Assche FA, Vandenberghe 
K. Alternative technique for Nd: YAG laser coagulation in twin-to-twin transfusion syndrome with 
anterior placenta. Ultrasound Obstet Gynecol. 1998;11(5):347-352. 
http://onlinelibrary.wiley.com/doi/10.1046/j.1469-0705.1998.11050347.x/full. 
98.  Draga E, Janiak K, Bielak A, et al. Fetal therapy- laser therapy of twin-to-twin transfusion 
syndrome /TTTS/. Polish Gynaecol. 2016;87(02):104-110. doi:10.17772/gp/61328. 
99.  Ek S, Kublickas M, Bui T-H, et al. Establishing a national program for fetoscopic guided laser 
occlusion for twin-to-twin transfusion syndrome in Sweden. Acta Obstet Gynecol Scand. 
2012;91(10):1196-1200. doi:10.1111/j.1600-0412.2012.01447.x. 
  
This article is protected by copyright. All rights reserved. 
100.  Habli M, Bombrys A, Lewis D, et al. Incidence of complications in twin-twin transfusion syndrome 
after selective fetoscopic laser photocoagulation: a single-center experience. Am J Obstet 
Gynecol. 2009;201(4):417. doi:10.1016/j.ajog.2009.07.046. 
101.  Has R, Kalelioglu I, Corbacioglu Esmer A, et al. Stage-related outcome after fetoscopic laser 
ablation in twin-to-twin transfusion syndrome. Fetal Diagn Ther. 2014;36(4):287-292. 
doi:10.1159/000362385. 
102.  Hernández-Andrade E, Guzmán-Huerta M, Benavides-Serralde JA, et al. [Laser ablation of the 
placental vascular anastomoses for the treatment of twin-to-twin transfusion syndrome]. Rev 
Invest Clin. 2011;63(1):46-52. 
103.  Ishii K, Nakata M, Wada S, Hayashi S, Murakoshi T, Sago H. Perinatal outcome after laser 
surgery for triplet gestations with feto-fetal transfusion syndrome. Prenat Diagn. 2014;34(8):734-
738. doi:10.1002/pd.4357. 
104.  Ishii K, Nakata M, Wada S, Murakoshi T, Sago H. Feasibility and preliminary outcomes of 
fetoscopic laser photocoagulation for monochorionic twin gestation with selective intrauterine 
growth restriction accompanied by severe oligohydramnios. J Obstet Gynaecol Res. 
2015;41(11):1732-1737. doi:10.1111/jog.12827. 
105.  Lanna MM, Faiola S, Consonni D, Rustico MA. Increased risk of placental abruption after 
solomon laser treatment of twin-twin transfusion syndrome. Placenta. 2017;53:54-56. 
doi:10.1016/j.placenta.2017.03.018. 
106.  Lecointre L, Sananès N, Weingertner AS, et al. Photocoagulation laser par fœtoscopie pour 
syndrome transfuseur-transfusé : analyse d’une série consécutive unicentrique de 200 cas. J 
Gynecol Obstet Hum Reprod. 2017;46(2):175-181. doi:10.1016/j.jogoh.2016.10.004. 
107.  Malshe A, Snowise S, Mann LK, et al. Preterm delivery after fetoscopic laser surgery for twin-
twin transfusion syndrome: etiology and risk factors. Ultrasound Obstet Gynecol. 
2017;49(5):612-616. doi:10.1002/uog.15972. 
108.  Middeldorp JM, Sueters M, Lopriore E, et al. Fetoscopic laser surgery in 100 pregnancies with 
severe twin-to-twin transfusion syndrome in the Netherlands. Fetal Diagn Ther. 
2007;22(3):190-194. http://gateway.proquest.com/openurl?ctx_ver=Z39.88-
2004&res_id=xri:pqm&req_dat=xri:pqil:pq_clntid=50325&rft_val_fmt=ori/fmt:kev:mtx:journal&g
enre=article&issn=1015-3837&volume=22&issue=3&spage=190. 
  
This article is protected by copyright. All rights reserved. 
109.  Miyadahira M, Brizot M, Carvalho M, et al. Type II and III Selective Fetal Growth Restriction: 
Perinatal Outcomes of Expectant Management and Laser Ablation of Placental Vessels. Clinics. 
2018;73:1-5. doi:10.6061/clinics/2018/e210. 
110.  Molina García FS, Zaragoza García E, Carrillo Badillo MP, Fernández de Santos AG, Calpena 
García A, Montoya Ventoso F. Implementación de la terapia láser endoscópica para las 
complicaciones de gestaciones gemelares monocoriales. Progresos en Obstet y Ginecol. 
2009;52(6):313-319. doi:10.1016/S0304-5013(09)71466-9. 
111.  Morris RK, Selman TJ, Harbidge A, Martin WI, Kilby MD. Fetoscopic laser coagulation for severe 
twin-to-twin transfusion syndrome: factors influencing perinatal outcome, learning curve of the 
procedure and lessons for new centres. BJOG. 2010;117(11):1350-1357. doi:10.1111/j.1471-
0528.2010.02680.x. 
112.  Nguyen HK, Cheng YW, Lee H, et al. 446: Recent experience with twin-twin transfusion 
syndrome: 2005-2011. Am J Obstet Gynecol. 2012;206(1):S205. 
doi:10.1016/j.ajog.2011.10.464. 
113.  Ozawa K, Sugibayashi R, Wada S, et al. Fetoscopic laser photocoagulation for amniotic fluid 
discordance bordering on twin–twin transfusion syndrome: Feasibility, perinatal and long-term 
outcomes. J Obstet Gynaecol Res. 2017;43(8):1256-1262. doi:10.1111/jog.13349. 
114.  Papanna R, Johnson A, Ivey RT, Olutoye OO, Cass D, Moise KJ. Laparoscopy-assisted 
fetoscopy for laser surgery in twin-twin transfusion syndrome with anterior placentation. 
Ultrasound Obstet Gynecol. 2010;35(1):65-70. doi:10.1002/uog.7495. 
115.  Papanna R, Habli M, Baschat AA, et al. Cerclage for cervical shortening at fetoscopic laser 
photocoagulation in twin-twin transfusion syndrome. Am J Obstet Gynecol. 2012;206(5):425. 
doi:10.1016/j.ajog.2012.02.022. 
116.  Peeters SHP, Stolk TT, Slaghekke F, et al. Iatrogenic perforation of intertwin membrane after 
laser surgery for twin-to-twin transfusion syndrome. Ultrasound Obstet Gynecol. 
2014;44(5):550-556. doi:10.1002/uog.13445. 
117.  Persico N, Fabietti I, D’Ambrosi F, Riccardi M, Boito S, Fedele L. Postnatal survival after 
endoscopic equatorial laser for the treatment of twin-to-twin transfusion syndrome. Am J Obstet 
Gynecol. 2016;214(4):533. doi:10.1016/j.ajog.2015.10.020. 
118.  Quintero RA, Comas C, Bornick PW, Allen MH, Kruger M. Selective versus non-selective laser 
  
This article is protected by copyright. All rights reserved. 
photocoagulation of placental vessels in twin-to-twin transfusion syndrome. Ultrasound Obstet 
Gynecol. 2000;16(3):230-236. http://onlinelibrary.wiley.com/doi/10.1046/j.1469-
0705.2000.00265.x/full. 
119.  Quintero RA, Bornick PW, Allen MH, Johson PK. Selective laser photocoagulation of 
communicating vessels in severe twin-twin transfusion syndrome in women with an anterior 
placenta. Obstet Gynecol. 2001;97(3):477-481. 
https://go.openathens.net/redirector/nhs?url=http%3A%2F%2Fovidsp.ovid.com%2Fovidweb.c
gi%3FT%3DJS%26PAGE%3Dfulltext%26MODE%3Dovid%26CSC%3DY%26NEWS%3DN%2
6D%3Dovft%26SEARCH%3D%252210.1016%2FS0029-7844(00)01172-8%2522.di. 
120.  Rossi AC, Kaufman MA, Bornick PW, Quintero RA. General vs local anesthesia for the 
percutaneous laser treatment of twin-twin transfusion syndrome. Am J Obstet Gynecol. 
2008;199(2):137. doi:10.1016/j.ajog.2007.12.008. 
121.  Ruano R, Brizot M de L, Liao AW, Zugaib M. Selective fetoscopic laser photocoagulation of 
superficial placental anastomoses for the treatment of severe twin-twin transfusion syndrome. 
Clinics (Sao Paulo). 2009;64(2):91-96. 
http://europepmc.org/search?query=(DOI:%2210.1590/S1807-59322009000200005%22). 
122.  Rüegg L, Hüsler M, Krähenmann F, Natalucci G, Zimmermann R, Ochsenbein-Kölble N. 
Outcome after fetoscopic laser coagulation in twin–twin transfusion syndrome – is the survival 
rate of at least one child at 6 months of age dependent on preoperative cervical length and 
preterm prelabour rupture of fetal membranes? J Matern Neonatal Med. 2018;0(0):1-9. 
doi:10.1080/14767058.2018.1506441. 
123.  Said S, Flood K, Breathnach F, et al. Fetoscopic laser treatment of twin-to-twintransfusion 
syndrome (TTTS). Ir Med J. 2008;101(6):191-193. 
124.  Senat M-V, Deprest J, Boulvain M, Paupe A, Winer N, Ville Y. Endoscopic laser surgery 
versus serial amnioreduction for severe twin-to-twin transfusion syndrome. N Engl J Med. 
2004;351(2):136-144. http://gateway.proquest.com/openurl?ctx_ver=Z39.88-
2004&res_id=xri:pqm&req_dat=xri:pqil:pq_clntid=50325&rft_val_fmt=ori/fmt:kev:mtx:journal&g
enre=article&issn=1533-4406&volume=351&issue=2&spage=136. 
125.  Sepulveda W, Wong AE, Dezerega V, Devoto JC, Alcalde JL. Endoscopic laser surgery in 
severe second-trimester twin-twin transfusion syndrome: a three-year experience from a Latin 
  
This article is protected by copyright. All rights reserved. 
American center. Prenat Diagn. 2007;27(11):1033-1038. 
https://go.openathens.net/redirector/nhs?url=http%3A%2F%2Fonlinelibrary.wiley.com%2Fdoi
%2F10.1002%2Fpd.1829%2Ffull. 
126.  Shamshirsaz AA, Javadian P, Ruano R, et al. Comparison between laparoscopically assisted 
and standard fetoscopic laser ablation in patients with anterior and posterior placentation in twin-
twin transfusion syndrome: a single center study. Prenat Diagn. 2015;35(4):376-381. 
doi:10.1002/pd.4552. 
127.  Slaghekke F, Lopriore E, Lewi L, et al. Fetoscopic laser coagulation of the vascular equator 
versus selective coagulation for twin-to-twin transfusion syndrome: an open-label randomised 
controlled trial. Lancet (London, England). 2014;383(9935):2144-2151. doi:10.1016/S0140-
6736(13)62419-8. 
128.  Taniguchi K, Sumie M, Sugibayashi R, Wada S, Matsuoka K, Sago H. Twin anemia-
polycythemia sequence after laser surgery for twin-twin transfusion syndrome and maternal 
morbidity. Fetal Diagn Ther. 2015;37(2):148-153. doi:10.1159/000365812. 
129.  Tchirikov M, Oshovskyy V, Steetskamp J, Falkert A, Huber G, Entezami M. Neonatal outcome 
using ultrathin fetoscope for laser coagulation in twin-to-twin-transfusion syndrome. J Perinat 
Med. 2011;39(6):725-730. doi:10.1515/JPM.2011.091. 
130.  Teoh M, Walker S, Cole S, Edwards A. “A problem shared is a problem halved”: success of a 
statewide collaborative approach to fetal therapy. Outcomes of fetoscopic laser 
photocoagulation for twin-twin transfusion syndrome in Victoria. Aust N Z J Obstet Gynaecol. 
2013;53(2):108-113. doi:10.1111/ajo.12062. 
131.  Thia E, Thain S, Yeo G. Fetoscopic laser photocoagulation in twin-to-twin transfusion syndrome: 
experience from a single institution. Singapore Med J. 2017;58(6):321-326. 
doi:10.11622/smedj.2016067. 
132.  Ville Y, Van Peborgh P, Gagnon A, Frydman R, Fernandez H. [Surgical treatment of twin-to-twin 
transfusion syndrome: coagulation of anastomoses with a Nd:YAG laser, under 
endosonographic control. Forty four cases]. J Gynecol Obstet Biol Reprod (Paris). 
1997;26(2):175-181. 
133.  Weingertner A-S, Kohler A, Mager C, et al. [Fetoscopic laser coagulation in 100 consecutive 
monochorionic pregnancies with severe twin-to-twin transfusion syndrome]. J Gynecol Obstet 
  
This article is protected by copyright. All rights reserved. 
Biol Reprod (Paris). 2011;40(5):444-451. doi:10.1016/j.jgyn.2011.04.001. 
134.  Wilson I, Henry A, Hinch E, et al. Audit of immediate outcomes for MCDA twins following laser 
therapy for twin-twin transfusion syndrome at the NSW Fetal Therapy Centre. Aust N Z J Obstet 
Gynaecol. 2016;56(3):289-294. doi:10.1111/ajo.12464. 
135.  Yang X, Leung TY, Ngan Kee WD, Chen M, Chan LW, Lau TK. Fetoscopic laser 
photocoagulation in the management of twin-twin transfusion syndrome: local experience from 
Hong Kong. Hong Kong Med J = Xianggang yi xue za zhi. 2010;16(4):275-281. 
136.  Zaretsky M V, Tong SH, Lagueux M, et al. North American Fetal Therapy Network: Indications 
for delivery following laser ablation for twin-twin transfusion syndrome. Am J Obstet Gynecol. 
2018;218(1):S316-S316. doi:10.1016/j.ajog.2017.11.055. 
137.  Zhao D, Cohen D, Middeldorp JM, et al. Histologic Chorioamnionitis and Funisitis After Laser 
Surgery for Twin-Twin Transfusion Syndrome. Obstet Gynecol. 2016;128(2):304-312. 
doi:10.1097/AOG.0000000000001469. 
138.  Bebbington MW, Danzer E, Moldenhauer J, Khalek N, Johnson MP. Radiofrequency ablation vs 
bipolar umbilical cord coagulation in the management of complicated monochorionic 
pregnancies. Ultrasound Obstet Gynecol. 2012;40(3):319-324. doi:10.1002/uog.11122. 
139.  Berg C, Holst D, Mallmann MR, Gottschalk I, Gembruch U, Geipel A. Early vs late intervention 
in twin reversed arterial perfusion sequence. Ultrasound Obstet Gynecol. 2014;43(1):60-64. 
doi:10.1002/uog.12578. 
140.  Deprest JA, Audibert F, Van Schoubroeck D, Hecher K, Mahieu-Caputo D. Bipolar coagulation 
of the umbilical cord in complicated monochorionic twin pregnancy. Am J Obstet Gynecol. 
2000;182(2):340-345. doi:10.1016/S0002-9378(00)70221-3. 
141.  Gouverneur M, Klumper F, Loproire E, Vandenbussche F, Oepkes D. Selectieve foeticide door 
navelstrengcoagulatie bij afwijkende monochoriale meerlingen. Ned Tijdschr Geneeskd. 
2009;153(19):906-911. 
142.  Gül A, Güngördük K, Yildirim G, et al. Bipolar cord coagulation in monochorionic twins discordant 
for major fetal anomalies. J Turkish Ger Gynecol Assoc. 2008;9(1):24-28. 
143.  Has R, Kalelioglu I, Esmer AC, et al. Bipolar cord coagulation in the management of complicated 
monochorionic twin pregnancies. Fetal Diagn Ther. 2014;36(3):190-195. 
doi:10.1159/000360853. 
  
This article is protected by copyright. All rights reserved. 
144.  He ZM, Fang Q, Yang YZ, et al. Fetal reduction by bipolar cord coagulation in managing 
complicated monochorionic multiple pregnancies: Preliminary experience in China. Chin Med J 
(Engl). 2010;123(5):549-554. doi:10.3760/cma.j.issn.0366-6999.2010.05.008. 
145.  Ilagan JG, Wilson RD, Bebbington M, et al. Pregnancy outcomes following bipolar umbilical cord 
cauterization for selective termination in complicated monochorionic multiple gestations. Fetal 
Diagn Ther. 2008;23(2):153-158. doi:10.1159/000111598. 
146.  Jelin E, Hirose S, Rand L, et al. Perinatal outcome of conservative management versus fetal 
intervention for twin reversed arterial perfusion sequence with a small acardiac twin. Fetal Diagn 
Ther. 2010;27(3):138-141. doi:10.1159/000295176. 
147.  King JR, Conturie CL, Ouzounian JG, Korst LM, Llanes A, Chmait RH. Umbilical Cord Occlusion 
via Laser Coagulation in Monochorionic Multifetal Gestations before and after 20 Weeks of 
Gestation. Fetal Diagn Ther. 2017;42(1):9-16. doi:10.1159/000448948. 
148.  Lanna MM, Rustico MA, Dell’Avanzo M, et al. Bipolar cord coagulation for selective feticide in 
complicated monochorionic twin pregnancies: 118 consecutive cases at a single center. 
Ultrasound Obstet Gynecol. 2012;39(4):407-413. doi:10.1002/uog.11073. 
149.  Lee H, Bebbington M, Crombleholme TM. The North American fetal therapy network registry 
data on outcomes of radiofrequency ablation for twin-reversed arterial perfusion sequence. Fetal 
Diagn Ther. 2013;33(4):224-229. doi:10.1159/000343223. 
150.  Nobili E, Paramasivam G, Kumar S. Outcome following selective fetal reduction in 
monochorionic and dichorionic twin pregnancies discordant for structural, chromosomal and 
genetic disorders. Aust N Z J Obstet Gynaecol. 2013;53(2):114-118. doi:10.1111/ajo.12071. 
151.  Paramasivam G, Wimalasundera R, Wiechec M, Zhang E, Saeed F, Kumar S. Radiofrequency 
ablation for selective reduction in complex monochorionic pregnancies. BJOG An Int J Obstet 
Gynaecol. 2010;117(10):1294-1298. doi:10.1111/j.1471-0528.2010.02624.x. 
152.  Peng R, Xie HN, Lin MF, et al. Clinical Outcomes after Selective Fetal Reduction of Complicated 
Monochorionic Twins with Radiofrequency Ablation and Bipolar Cord Coagulation. Gynecol 
Obstet Invest. 2016;81(6):552-558. doi:10.1159/000445291. 
153.  Quintero RA, Romero R, Reich H, et al. In utero percutaneous umbilical cord ligation in the 
management of complicated monochorionic multiple gestations. Ultrasound Obstet Gynecol. 
1996;8(1):16-22. http://onlinelibrary.wiley.com/doi/10.1046/j.1469-0705.1996.08010016.x/full. 
  
This article is protected by copyright. All rights reserved. 
154.  Quintero RA, Chmait RH, Murakoshi T, et al. Surgical management of twin reversed arterial 
perfusion sequence. Am J Obstet Gynecol. 2006;194(4):982-991. 
doi:10.1016/j.ajog.2005.10.195. 
155.  Roman A, Papanna R, Johnson A, et al. Selective reduction in complicated monochorionic 
pregnancies: Radiofrequency ablation vs. bipolar cord coagulation. Ultrasound Obstet Gynecol. 
2010;36(1):37-41. doi:10.1002/uog.7567. 
156.  Schou K V., Jensen LN, Jørgensen C, Søgaard K, Tabor A, Sundberg K. Ultrasound-Guided 
Bipolar Umbilical Cord Occlusion in Complicated Monochorionic Pregnancies: Is There a 
Learning Curve. Fetal Diagn Ther. 2018;44(1):65-71. doi:10.1159/000479104. 
157.  Sugibayashi R, Ozawa K, Sumie M, Wada S, Ito Y, Sago H. Forty cases of twin reversed arterial 
perfusion sequence treated with radio frequency ablation using the multistep coagulation 
method: A single-center experience. Prenat Diagn. 2016;36(5):437-443. doi:10.1002/pd.4800. 
158.  Takano M, Murata S, Fujiwara M, Hirata H, Nakata M. Experience of fetoscopic laser 
photocoagulation and cord transection for twin-reversed arterial perfusion sequence. J Obstet 
Gynaecol Res. 2015;41(9):1326-1329. doi:10.1111/jog.12720. 
159.  Tsao KJ, Feldstein VA, Albanese CT, et al. Selective reduction of acardiac twin by 
radiofrequency ablation. Am J Obstet Gynecol. 2002;187(3):635-640. 
doi:10.1067/mob.2002.125242. 
160.  Zhang ZT, Yang T, Liu CX, Li N. Treatment of twin reversed arterial perfusion sequence with 
radiofrequency ablation and expectant management: A single center study in China. Eur J 
Obstet Gynecol Reprod Biol. 2018;225:9-12. doi:10.1016/j.ejogrb.2018.03.046. 
161.  Deprest J, Jani J, Gratacos E, et al. Fetal intervention for congenital diaphragmatic hernia: the 
European experience. Semin Perinatol. 2005;29(2):94-103. 
162.  Harrison M, Keller R, Hawgood S. A randomized trial of fetal endoscopic tracheal occlusion for 
severe fetal congential diaphragmatic hernia. N Engl J Med. 2003;349:1916-1924. 
163.  Jani J, Gratacós E, Greenough A, et al. Percutaneous fetal endoscopic tracheal occlusion 
(FETO) for severe left-sided congenital diaphragmatic hernia. Clin Obstet Gynecol. 
2005;48(4):910-922. 
https://go.openathens.net/redirector/nhs?url=http%3A%2F%2Fovidsp.ovid.com%2Fovidweb.c
gi%3FT%3DJS%26PAGE%3Dfulltext%26MODE%3Dovid%26CSC%3DY%26NEWS%3DN%2
  
This article is protected by copyright. All rights reserved. 
6D%3Dovft%26SEARCH%3D%252210.1097%2F01.grf.0000184774.02793.0c%2522.di. 
164.  Jani JC, Nicolaides KH, Gratacós E, Vandecruys H, Deprest JA, Group FT. Fetal lung-to-head 
ratio in the prediction of survival in severe left-sided diaphragmatic hernia treated by fetal 
endoscopic tracheal occlusion (FETO). Am J Obstet Gynecol. 2006;195(6):1646-1650. 
https://auth.elsevier.com/ShibAuth/institutionLogin?entityID=https://idp.eng.nhs.uk/openathens
&appReturnURL=https%3A%2F%2Fwww.clinicalkey.com%2Fcontent%2FplayBy%2Fdoi%2F
%3Fv%3D10.1016%2Fj.ajog.2006.04.004. 
165.  Jani JC, Nicolaides KH, Gratacós E, et al. Severe diaphragmatic hernia treated by fetal 
endoscopic tracheal occlusion. Ultrasound Obstet Gynecol. 2009;34(3):304-310. 
doi:10.1002/uog.6450. 
166.  Kosinski P, Wielgos M. Foetoscopic endotracheal occlusion (FETO) for severe isolated left-
sided congenital diaphragmatic hernia: single center Polish experience. J Matern Neonatal Med. 
2018;31(19):2521-2526. doi:10.1080/14767058.2017.1344969. 
167.  Manrique S, Munar F, Andreu E, et al. [Fetoscopic tracheal occlusion for the treatment of severe 
congenital diaphragmatic hernia: preliminary results]. Rev Esp Anestesiol Reanim. 
2008;55(7):407-413. 
168.  Peralta CFA, Sbragia L, Bennini JR, et al. Fetoscopic endotracheal occlusion for severe isolated 
diaphragmatic hernia: Initial experience from a single clinic in Brazil. Fetal Diagn Ther. 
2011;29(1):71-77. doi:10.1159/000314617. 
169.  Persico N, Fabietti I, Ciralli F, et al. Fetoscopic Endoluminal Tracheal Occlusion in Fetuses with 
Severe Diaphragmatic Hernia: A Three-Year Single-Center Experience. Fetal Diagn Ther. 
2017;41(3):215-219. doi:10.1159/000448096. 
170.  Ruano R, da Silva MM, Campos JADB, et al. Fetal pulmonary response after fetoscopic tracheal 
occlusion for severe isolated congenital diaphragmatic hernia. Obstet Gynecol. 2012;119(1):93-
101. doi:10.1097/AOG.0b013e31823d3aea. 
171.  Ruano R, Yoshisaki CT, da Silva MM, et al. A randomized controlled trial of fetal endoscopic 
tracheal occlusion versus postnatal management of severe isolated congenital diaphragmatic 
hernia. Ultrasound Obstet Gynecol. 2012;39(1):20-27. doi:10.1002/uog.10142. 
172.  Ruano R, Peiro JL, da Silva MM, et al. Early fetoscopic tracheal occlusion for extremely severe 
pulmonary hypoplasia in isolated congenital diaphragmatic hernia: preliminary results. 
  
This article is protected by copyright. All rights reserved. 
Ultrasound Obstet Gynecol. 2013;42(1):70-76. doi:10.1002/uog.12414. 
173.  Arens C, Koch C, Veit M, et al. Anesthetic Management for Percutaneous Minimally Invasive 
Fetoscopic Surgery of Spina Bifida Aperta: A Retrospective, Descriptive Report of Clinical 
Experience. Anesth Analg. 2017;125(1):219-222. doi:10.1213/ANE.0000000000001896. 
174.  Belfort MA, Whitehead WE, Shamshirsaz AA, et al. Fetoscopic Open Neural Tube Defect 
Repair: Development and Refinement of a Two-Port, Carbon Dioxide Insufflation Technique. 
Obstet Gynecol. 2017;129(4):734-743. doi:10.1097/AOG.0000000000001941. 
175.  Degenhardt J, Schürg R, Winarno A, et al. Percutaneous minimal-access fetoscopic surgery for 
spina bifida aperta. Part II: maternal management and outcome. Ultrasound Obstet Gynecol. 
2014;44(5):525-531. doi:10.1002/uog.13389. 
176.  Kohn J, Rao V, Sellner A, et al. Management of labor and delivery after fetoscopic repair of an 
open neural tube defect. Obs Gynecol. 2018;131(6):1062-1068. 
doi:10.1097/AOG.0000000000002577. 
177.  Pedreira DAL, Zanon N, de Sá RAM, et al. Fetoscopic single-layer repair of open spina bifida 
using a cellulose patch: preliminary clinical experience. J Matern Fetal Neonatal Med. 
2014;27(16):1613-1619. doi:10.3109/14767058.2013.871701. 
178.  Pedreira DAL, Zanon N, Nishikuni K, et al. Endoscopic surgery for the antenatal treatment of 
myelomeningocele: the CECAM trial. Am J Obstet Gynecol. 2016;214(1):111. 
doi:10.1016/j.ajog.2015.09.065. 
179.  Verbeek RJ, Heep A, Maurits NM, et al. Fetal endoscopic myelomeningocele closure preserves 
segmental neurological function. Dev Med Child Neurol. 2012;54(1):15-22. doi:10.1111/j.1469-
8749.2011.04148.x. 
180.  Ziemann M, Fimmers R, Khaleeva A. Partial amniotic carbon dioxide insufflation (PACI) during 
minimally invasive fetoscopic interventions on fetuses with spina bifida aperta. Surg Endosc. 
2018;Epub ahead. doi:doi: 10.1007/s00464-018-6029-z. 
181.  Morris RK, Malin GL, Quinlan-Jones E, et al. Percutaneous vesicoamniotic shunting versus 
conservative management for fetal lower urinary tract obstruction (PLUTO): A randomised trial. 
Lancet. 2013;382(9903):1496-1506. doi:10.1016/S0140-6736(13)60992-7. 
182.  Ruano R, Duarte S, Bunduki V, Giron AM, Srougi M, Zugaib M. Fetal cystoscopy for severe 
lower urinary tract obstruction--initial experience of a single center. Prenat Diagn. 2010;30(1):30-
  
This article is protected by copyright. All rights reserved. 
39. doi:10.1002/pd.2418. 
183.  Welsh A, Agarwal S, Kumar S, Smith RP, Fisk NM. Fetal cystoscopy in the management of fetal 
obstructive uropathy: Experience in a single European centre. Prenat Diagn. 2003;23(13):1033-
1041. doi:10.1002/pd.717. 
184.  Cavalheiro S, Moron AF, Almodin CG, et al. Fetal hydrocephalus. Childs Nerv Syst. 
2011;27(10):1575-1583. doi:10.1007/s00381-011-1539-1. 
185.  Mallmann MR, Graham V, Rösing B, et al. Thoracoamniotic Shunting for Fetal Hydrothorax: 
Predictors of Intrauterine Course and Postnatal Outcome. Fetal Diagn Ther. 2017;41(1):58-65. 
doi:10.1159/000446110. 
186.  Nivatpumin P, Pangthipampai P, Jirativanont T, Dej-Arkom S, Triyasunant N, Tempeetikul T. 
Anesthetic Techniques and Incidence of Complications in Fetoscopic Surgery. J Med Assoc 
Thai. 2016;99(5):602-610. 
187.  Peralta CFA, Sbragia L, Corrêa-Silva EP de B, et al. [Maternal complications following 
endoscopic surgeries in fetal Medicine]. Rev Bras Ginecol Obstet. 2010;32(6):260-266. 
188.  E.A. T. Maternal reproductive outcomes after in-utero repair of myelomeningocele. Am J Obstet 
Gynecol. 2016;214(1). http://www.hlisd.org/LibraryDetail.aspx?LibraryID=3866. 
189.  Wilson RD, Lemerand K, Johnson MP, et al. Reproductive outcomes in subsequent pregnancies 
after a pregnancy complicated by open maternal-fetal surgery (1996-2007). Am J Obstet 
Gynecol. 2010;203(3):209. doi:10.1016/j.ajog.2010.03.029. 
190.  Gregoir C, Engels AC, Gomez O, et al. Fertility, pregnancy and gynecological outcomes after 
fetoscopic surgery for congenital diaphragmatic hernia. Hum Reprod. 2016;31(9):2024-2030. 
doi:10.1093/humrep/dew160. 
191.  Le Lous M, Mediouni I, Chalouhi G, et al. Impact of laser therapy for twin-to-twin transfusion 
syndrome on subsequent pregnancy. Prenat Diagn. 2018;38(4):293-297. doi:10.1002/pd.5227. 
192.  Vergote S, Lewi L, Gheysen W, De Catte L, Devlieger R, Deprest J. Subsequent fertility, 
pregnancy, and gynecologic outcomes after fetoscopic laser therapy for twin-twin transfusion 
syndrome compared with normal monochorionic twin gestations. Am J Obstet Gynecol. 
2018;218(4):447.e1-447.e7. doi:10.1016/j.ajog.2018.01.013. 
  
  
This article is protected by copyright. All rights reserved. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Flow diagram of study selection adapted from PRISMA 20098 
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Table 1: Included studies of open fetal surgery.  
 
Category First author and year of 
publication 
Condition Procedure Study 
design 
No. of 
patients 
EXIT Barthod 201356 Neck mass, CHAOS EXIT Case series 5 
Cass 201357 Lung mass, mediastinal mass EXIT Case series 9 
Chen 201858 Omphalocele EXIT Case control 7 
Dahlgren 200459 Head or neck tumour EXIT Case series 4 
Flake 2000†35 CDH EXIT Case series 15 
George 200760 Skeletal dysplasia, micrognathia EXIT Case series 3 
Hedrick 200361 Multiple EXIT Case series 43 
Hedrick 200562 Lung lesions EXIT Case series 9 
Kern 200763 CCAM, hydrothorax EXIT Case series 5 
Kornacki 201764 Neck mass, CHAOS EXIT Case series 4 
Kunisaki 200765 CDH EXIT Case control 14 
Laje 201266 Cervical teratoma EXIT Case series 17 
Laje 201367 Neck mass EXIT Case series 4 
Laje 201568 Cervical lymphatic mass EXIT Case series 13 
Lazar 201169 Neck mass EXIT Case series 12 
Noah 200270 Not stated EXIT Case control 34 
Pellicer 200771 Neck mass EXIT Case series 3 
Stoffan 201272 CDH EXIT Case control 7 
Tuncay Ozgunen 201073 Neck mass EXIT Case series 3 
Zamora 2013†‡74 MMC, lung mass, SCT EXIT Case series 26 
MMC Bennett 201434 MMC Neurosurgical repair Case control 43 
Botelho 201775 MMC Neurosurgical repair Case series 45 
Bruner 199918 MMC Neurosurgical repair Case control 29 
Bruner 2000*76 MMC Neurosurgical repair Case control 4 
Farmer 200377 MMC Neurosurgical repair Case series 12 
Friszer 201678 MMC Neurosurgical repair Case series 3 
Johnson 201679 MMC Neurosurgical repair Randomised 91 
Marenco 201380 MMC Neurosurgical repair Case series 4 
Moldenhauer 201539 MMC Neurosurgical repair Case series 100 
Moron 201819 MMC Neurosurgical repair Case series 237 
Ochsenbein-Kolble 201720 MMC Neurosurgical repair Case control 30 
Sinskey 201717 MMC Neurosurgical repair Case series 47 
Soni 201681 MMC Neurosurgical repair Case series 88 
Zamlynski 201432 MMC Neurosurgical repair Case control 46 
CDH Flake 2000†35 CDH Tracheal occlusion Case series 15 
Harrison 199082 CDH Diaphragm repair Case series 6 
Harrison 199383 CDH Diaphragm repair Case series 14 
Harrison 1998*84 CDH Tracheal occlusion Case control 13 
CCAM Adzick 200385 CCAM Lung resection Case series 22 
SCT Hedrick 200486 SCT Debulking Case series 4 
Mixed Golombeck 2006†*6 MMC, CCAM, SCT Mixed Case control 79 
Longaker 199187 LUTO, CDH, SCT, CCAM Mixed Case series 17 
Zamora 2013†‡74 MMC, lung mass, SCT Mixed Case series 7 
TOTAL    43 studies 1193 
patients 
 
† Studies including patients undergoing a primary fetal and later an EXIT procedure. 
* Studies including both open and fetoscopic procedures, also included in Table 2 
‡ Studies including immediate and late complications, also included in Table 3 
CCAM - congenital cystic adenomatoid malformation, CDH - congenital diaphragmatic hernia, 
CHAOS - congenital high airway obstruction syndrome, EXIT - ex-utero intrapartum treatment, LUTO 
- lower urinary tract obstruction, MMC - myelomeningocele, SCT - sacrococcygeal teratoma 
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Table 2: Included studies of fetoscopic surgery. 
Category First author and year of 
publication 
Condition Procedure Study 
design 
No. of 
patients 
Multiple 
pregnancy 
complications 
treated with 
laser 
Aboudiab 201788 TTTS Laser photocoagulation Case series 18 
Baschat 201389 TTTS Laser photocoagulation Case control 147 
Chalouhi 201690 TTTS (triplets) Laser photocoagulation Case series  22 
Chang 200621 TTTS Laser photocoagulation Case series 27 
Chang 201691 TTTS Laser photocoagulation Case control 100 
Chmait 201331 TTTS Laser photocoagulation Case control 318 
Chmait 201792 TTTS Laser photocoagulation Case series 19 
Crombleholme 200793 TTTS Laser photocoagulation Randomised 20 
De Lia 199594 TTTS Laser photocoagulation Case series 26 
De Lia 199995 TTTS Laser photocoagulation Case series 67 
De Lia 200996 TTTS (triplets) Laser photocoagulation Case series 10 
Deprest 199897 TTTS Laser photocoagulation Case series 6 
Draga 201698 TTTS Laser photocoagulation Case series 37 
Duron 201436 TTTS Laser photocoagulation Case control 85 
Ek 201299 TTTS Laser photocoagulation Case series 67 
Habli 2009100 TTTS Laser photocoagulation Case series 152 
Has 2014101 TTTS Laser photocoagulation Case series 85 
Hecher 200041 TTTS Laser photocoagulation Case control 200 
Hernandez-Andrade 
2011102 
TTTS Laser photocoagulation Case series 
35 
Huber 200822 TTTS Laser photocoagulation Case control 176 
Ishii 2014103 TTTS (triplets) Laser photocoagulation Case series 16 
Ishii 2015104 sFGR Laser photocoagulation Case series 10 
Lanna 2017105 TTTS Laser photocoagulation Case control 373 
Lecointre 2017106 TTTS Laser photocoagulation Case control 200 
Malshe 2017107 TTTS Laser photocoagulation Case series 203 
Martinez 201242 TTTS Laser photocoagulation Case series 500 
Middeldorp 2007108 TTTS Laser photocoagulation Case series 100 
Miyadahira 2018109 sFGR Laser photocoagulation Case control 67 
Molina-Garcia 2009110 TTTS, sFGR Laser photocoagulation Case series 22 
Morris 2010111 TTTS Laser photocoagulation Case series 164 
Mullers 201516 TTTS Laser photocoagulation Case series 105 
Nakata 201637 TTTS Laser photocoagulation Case series 6 
Nguyen 2012112 TTTS Laser photocoagulation Case series 98 
Ozawa 2017113 Amniotic fluid 
discordance 
Laser photocoagulation Case series 11 
Papanna 2010114 TTTS Laser photocoagulation Case control 48 
Papanna 2012115 TTTS Laser photocoagulation Case control 163 
Peeters 2014116 TTTS Laser photocoagulation Case control 338 
Persico 2016117 TTTS Laser photocoagulation Case series 106 
Quintero 2000118 TTTS Laser photocoagulation Case control 92 
Quintero 2001119 sFGR Laser photocoagulation Case series 11 
Rossi 2008120 TTTS Laser photocoagulation Case control 266 
Ruano 2009121 TTTS Laser photocoagulation Case series 19 
Ruegg 2018122 TTTS Laser photocoagulation Case control 37 
Rustico 201238 TTTS Laser photocoagulation Case series 150 
Said 2008123 TTTS Laser photocoagulation Case series 10 
Senat 2004124 TTTS Laser photocoagulation Randomised 72 
Sepulveda 2007125 TTTS Laser photocoagulation Case series 33 
Shamshirsaz 2015126 TTTS Laser photocoagulation Case control 55 
Slaghekke 2014127 TTTS Laser photocoagulation Randomised 274 
Taniguchi 2015128 TTTS Laser photocoagulation Case series 3 
Tchirikov 2011129 TTTS Laser photocoagulation Case control 80 
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Teoh 2013130 TTTS Laser photocoagulation Case series 49 
Thia 2017131 TTTS Laser photocoagulation Case series 5 
Ville 1997132 TTTS Laser photocoagulation Case series 132 
Ville 199826 TTTS Laser photocoagulation Case control 44 
Weingertner 2011133 TTTS Laser photocoagulation Case series 100 
Wilson 2016134 TTTS Laser photocoagulation Case series 151 
Yamamoto 200528 TTTS Laser photocoagulation Case series 175 
Yang 2010135 TTTS Laser photocoagulation Case series 30 
Zaretsky 2018136 TTTS Laser photocoagulation Case series 749 
Zhao 2016137 TTTS Laser photocoagulation Case control 62 
Multiple 
pregnancy 
complications 
treated with 
selective 
reduction 
Bebbington 2012138 TTTS, TRAP, sFGR, 
discordant anomaly 
RFA Case control 146 
Berg 2014139 TRAP RFA Case control 7 
Delabaere 201323 TTTS, TRAP, sFGR, 
discordant anomaly 
BCC, cord compression, 
cord ligation 
Case series 30 
Deprest 2000140 TTTS, TRAP BCC Case series 10 
Gallot 200324 TTTS, TRAP CO Case series 11 
Gouverneur 2009141 TTTS, TRAP, sFGR, 
discordant anomaly 
BCC, laser cord 
photocoagulation 
Case series 54 
Gul 2008142 TTTS, TRAP, 
discordant anomaly 
BCC Case series 9 
Has 2014143 TTTS, TRAP, sFGR, 
discordant anomaly 
BCC Case series 71 
He 2010144 TTTS, TRAP, sFGR, 
discordant anomaly 
BCC Case series 14 
Ilagan 2008145 TTTS, TRAP, 
discordant anomaly 
BCC Case series 27 
Jelin 2010146 TRAP RFA Case control 7 
King 2017147 TRAP, discordant 
anomaly 
Laser cord 
photocoagulation 
Case series 43 
Lanna 2012148 TTTS, TRAP, sFGR, 
discordant anomaly 
BCC Case series 118 
Lee 2013149 TRAP RFA Case series 98 
Lewi 200630 TTTS, TRAP, sFGR, 
discordant anomaly 
Laser cord 
photocoagulation 
Case series 80 
Moise 200833 TTTS, discordant 
anomaly 
RFA Case series 9 
Nobili 2013150 Discordant anomaly BCC Case series 48 
Paramasivam 2010151 TTTS, TRAP, sFGR, 
discordant anomaly 
RFA Case series 35 
Peng 2016152 TTTS, TRAP, sFGR, 
discordant anomaly, 
TAPS 
BCC Case control 93 
Quintero 1996153 TTTS, TRAP, 
discordant anomaly 
CO Case series 13 
Quintero 2006154 TRAP CO or laser 
photocoagulation 
Case control 51 
Roman 2010155 TTTS, TRAP, sFGR, 
discordant anomaly 
RFA Case control 60 
Schou 2018156 TTTS, TRAP, sFGR, 
discordant anomaly 
BCC Case control 102 
Sugibayashi 2016157 TRAP RFA Case series 40 
Takano 2015158 TRAP Laser photocoagulation +/- 
transection of cord (MCMA) 
Case series 10 
Taylor 200229 TTTS BCC Case series 15 
Tsao 2002159 TRAP RFA Case series 13 
Zhang 2018160 TRAP RFA Case series 25 
CDH Deprest 2005161 CDH FETO Case series 20 
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Harrison 1998*84 CDH Tracheal clip Case control 8 
Harrison 2003162 CDH FETO Randomised 11 
Jani 2005163 CDH FETO Case series 24 
Jani 2006164 CDH FETO Case series 28 
Jani 2009165 CDH FETO Case series 210 
Jimenez 201740 CDH Fetoscopic balloon removal Case control 201 
Kosinski 2017166 CDH FETO Case series 28 
Manrique 2008167 CDH FETO Case control 11 
Peralta 2011168 CDH FETO Case series 8 
Persico 2017169 CDH FETO Case series 21 
Ruano 2012170 CDH FETO Case control 35 
Ruano 2012171 CDH FETO Randomised 20 
Ruano 2013172 CDH FETO Case control 17 
MMC Arens 2017173 MMC Patch Case series 59 
Belfort 2017174 MMC Single layer suture (skin + 
dura) 
Case series 22 
Bruner 2000*76 MMC Maternal skin graft Case control 4 
Degenhardt 2014175 MMC Patch Case series 51 
Kohn 2018176 MMC Patch Case series 34 
Pedreira 2014177 MMC Patch + skin suture Case series 4 
Pedreira 2016178 MMC Patch + skin suture Case series 10 
Verbeek 2012179 MMC Patch Case control 19 
Ziemann 2018180 MMC Patch Case series 65 
LUTO Morris 2013181 LUTO Vesicoamniotic shunting Randomised 16 
Ruano 2010182 LUTO Cystoscopy Case control 11 
Welsh 2003183 LUTO Cystoscopy Case series 13 
Shunts Cavalheiro 2011184 Ventriculomegaly Shunting Case series 30 
Mallman 2017185 Hydrothorax Shunting Case series 78 
Mixed Golombeck 2006*6 TTTS, TRAP, CDH, 
LUTO 
Mixed Case control 99 
Kohl 200627 MMC, CDH, CHAOS Mixed Case series 16 
Kohl 201025 MMC, TTTS, CDH, 
CHAOS, ABS 
Mixed Case series 37 
Nivatpumin 2016186 TTTS, LUTO, CDH, 
TRAPS 
Mixed Case series 152 
Peralta 2010187 TTTS, CDH, TRAP Mixed Case series 56 
TOTAL    122 studies 9403 
patients 
 
* Studies including both open and fetoscopic procedures, also included in Table 1 
BCC - bipolar cord coagulation, CDH - congenital diaphragmatic hernia, CHAOS - congenital high 
airway obstruction syndrome, CO - cord occlusion, FETO - fetoscopic endoluminal tracheal occlusion, 
LUTO - lower urinary tract obstruction, MCMA - monochorionic monoamniotic, MMC - 
myelomeningocele, RFA - cord radiofrequency ablation, sFGR - selective fetal growth restriction, 
TAPS - twin anaemia-polycythaemia sequence, TO - tracheal occlusion, TRAP - twin reversed arterial 
perfusion sequence, TTTS - twin-to-twin transfusion syndrome. 
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Table 3: Included studies of open and fetoscopic surgery focusing on late 
complications. 
 
First author and year of 
publication 
Type of surgery Condition Study design Number of 
patients 
Farrell 19994 Open CDH, CCAM, LUTO, SCT,  Case series 45 
Thom 2016188 Open MMC Randomised 87 
Wilson 2010189 Open MMC, CCAM, CDH, SCT, 
mediastinal teratoma Case series 47 
Zamora 2013‡74 Open MMC, lung mass, SCT, EXIT Case series 33 
Gregoir 2016190 Fetoscopic CDH Case control 89 
Le Lous 2018191 Fetoscopic TTTS Case control 122 
Vergote 2018192 Fetoscopic TTTS Case control 92 
TOTAL   7 studies 515 
patients 
 
‡ Studies including immediate and late complications, also included in Table 1 
CCAM - congenital cystic adenomatoid malformation, CDH - congenital diaphragmatic hernia, EXIT - 
ex-utero intrapartum treatment, LUTO - lower urinary tract obstruction, MMC - myelomeningocele, 
SCT - sacrococcygeal teratoma, TTTS - twin-to-twin transfusion syndrome 
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Table 4: Maternal complications occurring with open or fetoscopic fetal surgery. 
Pooled proportions calculated using random effect model for meta-analysis  
 
Severe complications 
 
Minor complications 
 
All complications 
 
Clavien-Dindo 
classification 
IV 
(requiring ICU care) 
III 
(requiring surgical intervention) 
I-II 
(requiring treatment) 
I - IV 
Open surgery 
n = 1193 
 
 
Complication n  Complication n  Complication n   
 
 
 
 
 
 
 
 
ALL COMPLICATIONS: 20.86%  
(95% CI 15.22-27.13) 
Severe infection  2  Haemorrhage requiring delivery 3  Bleeding during procedure 13 
Pulmonary oedema 4 Placental abruption 28  Transfusion during/after procedure 41 
Complete heart block†a 1  Bowel obstruction 1  Chorioamnionitis/ endometritis 45  
  Wound drainage 2  Other infections†b 8  
  Uterine rupture 5  Pulmonary oedema 50 
  Laparotomy/ dehiscence repair 1 Transfusion at delivery 17  
  Caesarean hysterectomy 1    
      
TOTAL SEVERE: 4.51%  
(95% CI 3.24-5.98) 
TOTAL MINOR: 16.26%  
(95% CI 11.17-22.09) 
Fetoscopic 
surgery  
n = 9403 
Maternal cardiac arrest and 
delivery by hysterotomy 
1 Sepsis requiring delivery 1 Bleeding during procedure 165   
 
 
 
 
 
 
 
 
 
 
 
ALL COMPLICATIONS: 6.15%  
(95% CI 4.93-7.49) 
Severe infection  2  Haemorrhage requiring delivery 8  Transfusion during/after procedure 16  
Pulmonary oedema  3  Placental abruption 159  Venous thromboembolism†c 2  
Lung collapse  1    Chorioamnionitis 114 
DIC + Caesarean hysterectomy 1    Other infections†d 2  
Amniotic fluid embolism 2   Pulmonary oedema 45 
    Upper GI bleed†e 1  
    Diathermy skin burns 4  
    “Epidural headache” + blood patch 1  
    Wound hernia 1  
    Pleural effusions 1  
      
TOTAL SEVERE: 1.66%  
(95% CI 1.19-2.20) 
TOTAL MINOR: 4.33%  
(95% CI 3.33-5.45) 
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n: number of women 
†a Complete heart block considered to be tocolysis-related (magnesium sulphate) 
†b Other infections in open surgery: wound (6), chest (1), urinary tract (1) 
†c Venous thromboembolism: confirmed pulmonary embolism (1); suspected PE with confirmed deep vein thrombosis (1)  
†d Other infections in fetoscopic surgery: wound (1), chest (1) 
†e Upper GI bleed considered to be tocolysis-related (indomethacin) 
 
  
  
This article is protected by copyright. All rights reserved. 
Table 5: Maternal complications according to type of fetal surgery in the six most common procedures. 
 
Severe complications 
 
Minor complications 
  
All complications 
 
Clavien-
Dindo 
classification 
IV 
(requiring ICU care) 
III 
(requiring surgical intervention) 
I-II 
(requiring treatment) 
I - IV 
EXIT 
n = 237 
Complication n  Complication n  Complication n   
 
 
 
 
 
 
ALL COMPLICATIONS: 20.19%  
(95% CI 4.93-7.49) 
  Placental abruption  5  Bleeding during procedure 11  
    Transfusion during/after procedure 19  
    Endometritis 10  
    Wound infection 5  
      
TOTAL SEVERE: 3.62%  
(95% CI 1.69-6.24) 
TOTAL MINOR: 17.53%  
(95% CI 9.86-26.86) 
Open MMC 
repair 
n = 779 
Severe infection  2  Haemorrhage requiring delivery 3  Bleeding during procedure 1   
 
 
 
 
 
 
ALL COMPLICATIONS: 11.54%  
(95% CI 7.73-15.99) 
Complete heart block 1  Placental abruption 16  Transfusion during/after procedure 5  
Pulmonary oedema 1  Bowel obstruction 1  Chorioamnionitis 21  
  Uterine rupture 4  Other infections†a 2  
  Caesarean hysterectomy 1  Pulmonary oedema 15  
    Transfusion at delivery 16 
      
TOTAL SEVERE: 3.35% 
(95% CI 1.70-5.53)  
TOTAL MINOR: 6.63% 
(95% CI 3.63-10.45) 
Fetoscopic 
MMC repair 
n = 268 
  Placental abruption 6  Bleeding during procedure 3   
 
 
 
ALL COMPLICATIONS: 12.49%  
(95% CI 4.83-23.06) 
    Chorioamnionitis 10  
    Pulmonary oedema 5  
      
TOTAL SEVERE: 2.75% 
(95% CI 0.56-6.52) 
TOTAL MINOR: 9.04% 
(95% CI 3.27-17.40) 
FETO 
(insertion or 
  Placental abruption 4  Bleeding during procedure 1   
     Transfusion during/after procedure 1  
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fetoscopic 
removal of 
balloon) 
n = 634 
    Chorioamnionitis 7   
 
 
 
ALL COMPLICATIONS: 3.44%  
(95% CI 0.98-7.32) 
    Wound infection 1  
    Pulmonary oedema 3  
      
TOTAL SEVERE: 1.08% 
(95% CI 0.23-2.54) 
TOTAL MINOR: 2.39% 
(95% CI 0.71-5.02)  
Fetoscopic 
laser photo-
coagulation  
n = 6746 
Maternal arrest and delivery  1 Haemorrhage requiring delivery 2  Bleeding during procedure 148   
 
 
 
 
 
 
 
 
 
ALL COMPLICATIONS: 5.86%  
(95% CI 4.33-7.61) 
Pulmonary oedema  3  Sepsis requiring delivery 1 Transfusion during/after procedure 9  
Lung collapse  1  Placental abruption 130 VTE†b 2  
Amniotic fluid embolism 2    “Epidural headache” + blood patch 1  
DIC + Caesarean 
hysterectomy 
1    Chorioamnionitis 68  
    Pulmonary oedema 11  
    Upper GI bleed†c 1  
    Wound hernia 1  
       
TOTAL SEVERE: 1.51% 
(95% CI 0.91-2.25) 
TOTAL MINOR: 4.03% 
(95% CI 2.73-5.56) 
Fetoscopic 
selective 
reduction 
n = 1239 
Severe infection  2  Haemorrhage requiring delivery 3 Bleeding during procedure 10   
 
 
 
 
 
ALL COMPLICATIONS: 5.20%  
(95% CI 3.00-7.96) 
  Placental abruption 14  Diathermy skin burns 4  
    Chorioamnionitis 19  
    Chest infection 1  
    Pleural effusion 1  
      
TOTAL SEVERE: 1.98% 
(95% CI 0.97-3.35) 
TOTAL MINOR: 3.00% 
(95% CI 1.68-4.68) 
 
Pooled proportions calculated using random effect model for meta-analysis  
n: number of women 
†a Other infections in MMC surgery: chest (1), urinary tract (1) 
†b Venous thromboembolism: confirmed pulmonary embolism (1); suspected PE with confirmed deep vein thrombosis (1) 
  
This article is protected by copyright. All rights reserved. 
†c Upper GI bleed considered to be tocolysis-related (indomethacin) 
EXIT - ex-utero intrapartum treatment, FETO - fetoscopic endoluminal tracheal occlusion, MMC - myelomeningocele, DIC - disseminated intravascular 
coagulation 
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Table 6: Long-term maternal complications following open and fetoscopic fetal 
surgery 
 
Pooled proportions calculated using random effect model for meta-analysis  
NR - not reported 
†a Variable denominator as not all outcomes were reported by all studies 
†b No meta-analysis possible as reported by single study 
†c Gynaecological surgery following open fetal surgery:  endometrial ablation (1), hysterectomy (6): 
caesarean hysterectomy (1), ovarian cysts+/-menstrual disorder (2), fibroids (1), unknown reason (2) 
 
 
 
  Open 
surgery†a 
 
% (95% CI) 
 
Fetoscopic 
surgery†a 
 
% (95% CI) 
 
Conception Women attempting further pregnancy 
 
50.11 
(21.55-78.63) 
51.76 
(18.63-84.03) 
Women conceiving further pregnancy 
 
48.33 
(26.74-70.26) 
48.20 
(31.46-65.16) 
New sub-fertility 
 
3.81 
(1.22-7.76) 
NR 
 
Pregnancy outcomes Miscarriage 
 
19.95 
(13.37-27.48) 
13.67 
(9.34-18.68) 
Pre-term delivery 
 
20.49 
(10.48-32.81) 
2.12 
(0.02-9.01) 
Uterine rupture 
 
6.89 
(1.34-16.27) 
0 
 
Uterine dehiscence 
 
11.09 
(5.34-18.59) 
NR 
Excessive bleeding at delivery 
 
6.84 
(2.16-13.88) 
5.52 
(2.83-9.03) 
Non-pregnancy Abdominal pain 
 
6.38†b 9.01 
(3.84-16.06) 
Abnormal menstrual bleeding 
 
NR 6.54 
(3.43-10.57) 
Gynaecological surgery†c 
 
8.68 
(1.81-19.96) 
NR 
Psychological symptoms 
 
9.09†b 
 
32.56 
(7.70-64.58) 
